WO1997041803A1 - Bifurcated stent and method for the manufacture of same - Google Patents

Bifurcated stent and method for the manufacture of same Download PDF

Info

Publication number
WO1997041803A1
WO1997041803A1 PCT/CA1997/000294 CA9700294W WO9741803A1 WO 1997041803 A1 WO1997041803 A1 WO 1997041803A1 CA 9700294 W CA9700294 W CA 9700294W WO 9741803 A1 WO9741803 A1 WO 9741803A1
Authority
WO
WIPO (PCT)
Prior art keywords
stent
section
stent section
bifurcated
method defined
Prior art date
Application number
PCT/CA1997/000294
Other languages
French (fr)
Inventor
Ian M. Penn
Donald R. Ricci
George A. Shukov
Original Assignee
Divysio Solutions Ulc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Divysio Solutions Ulc. filed Critical Divysio Solutions Ulc.
Priority to JP53936697A priority Critical patent/JP4659159B2/en
Priority to AU23773/97A priority patent/AU2377397A/en
Priority to EP97919222A priority patent/EP0959811B1/en
Priority to AT97919222T priority patent/ATE270860T1/en
Priority to CA2253546A priority patent/CA2253546C/en
Priority to DE69729886T priority patent/DE69729886T2/en
Priority to US09/180,146 priority patent/US6811566B1/en
Publication of WO1997041803A1 publication Critical patent/WO1997041803A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/856Single tubular stent with a side portal passage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/954Instruments specially adapted for placement or removal of stents or stent-grafts for placing stents or stent-grafts in a bifurcation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/852Two or more distinct overlapping stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/065Y-shaped blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/065Y-shaped blood vessels
    • A61F2002/067Y-shaped blood vessels modular
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2002/828Means for connecting a plurality of stents allowing flexibility of the whole structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91525Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91566Adjacent bands being connected to each other connected trough to trough
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91575Adjacent bands being connected to each other connected peak to trough
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
    • A61F2210/0023Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at different temperatures whilst inside or touching the human body, heated or cooled by external energy source or cold supply
    • A61F2210/0042Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at different temperatures whilst inside or touching the human body, heated or cooled by external energy source or cold supply using a fluid, e.g. circulating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0058Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements soldered or brazed or welded
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2240/00Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2240/001Designing or manufacturing processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/006Additional features; Implant or prostheses properties not otherwise provided for modular

Definitions

  • the present invention relates to a bifurcated stent and to a method for the manufacture and delivery of a bifurcated stent.
  • Stents are generally known. Indeed, the term “stent” has been used interchangeably with terms such as “intraluminal vascular graft” and “expansible prosthesis”. As used throughout this specification the term “stent” is intended to have a broad meaning and encompasses any expandable prosthetic device for implantation in a body passageway (e.g., a lumen or artery).
  • a body passageway e.g., a lumen or artery
  • body passageway is intended to have a broad meaning and encompasses any duct (e.g. , natural or iatrogenic) within the human body and can include a member selected from the group comprising: blood vessels, respiratory ducts, gastrointestinal ducts and the like.
  • a stent in association with a balloon, is delivered to the target area of the body passageway by a catheter system.
  • the balloon is expanded thereby expanding the stent, e.g. by plastic deformation of the stent structure, so that the latter is urged in place against the body passageway.
  • the amount of force applied is at least that necessary to maintain the patency of the body passageway.
  • the balloon is deflated and withdrawn within the catheter, and subsequently removed.
  • the stent will remain in place and maintain the target area of the body passageway substantially free of blockage (or narrowing).
  • a stent which has gained some notoriety in the art is known as the
  • Palmaz-SchatzTM Balloon Expandable Stent (hereinafter referred to as "the Palmaz-Schatz stent").
  • This stent is discussed in a number of patents including United States patents 4,733,665, 4,739,762, 5,102,417 and 5,316,023, the contents of each of which are hereby inco ⁇ orated by reference.
  • Another stent which has gained some notoriety in the art is known as
  • Gianturco-Roubin Flex-StentTM (hereinafter referred to as "the Gianturco- Roubin stent").
  • This stent is discussed in a number of patents including United States patents 4,800,882, 4,907,336 and 5,041,126, the contents of each of which are hereby incorporated by reference.
  • Other types of stents are disclosed in the following patents:
  • Palmaz-Schatz stent admittedly shields side branches emanating from the target area of the body passageway effectively permanently.
  • United States patent 4,994,071 discloses a bifurcating stent apparatus.
  • the particular design inco ⁇ orates a series of generally parallel oriented loops interconnected by a sequence of "half-birch" connections.
  • the lattice structure of the illustrated stent is constructed of wire.
  • the use of such wire is important to obtain the loop structure of the illustrated design.
  • the use of a wire loop construction is disadvantageous since it is complicated to manufacture and the resulting stent is subject to expansion variability (e.g. variable post-expansion distortion and the like).
  • the present invention provides an expandable bifurcated stent comprising a proximal end and a distal end in communication with one another, the proximal end comprising a primary passageway and the distal end comprising a pair of secondary passageways, each secondary passageway in communication with the primary passageway at a first intersection, the stent being expandable from a first, contracted position to a second, expanded position upon the application of a radially outward force exerted on the stent, each of the primary passageway and the secondary passageways being constructed of a tubular wall having a porous surface, at least one connection portion being disposed at the first intersection for reinforcing the first intersection.
  • the present invention provides expandable bifurcated stent comprising a proximal end and a distal end in communication with one another, the proximal end comprising a primary passageway and the distal end comprising a pair of secondary passageways, each secondary passageway in communication with the primary passageway at a first intersection, the stent being expandable from a first, contracted position to a second, expanded position upon the application of a radially outward force exerted on the stent, each of the primary passageway and the secondary passageways having a porous surface, at least one connection portion interconnecting the pair of secondary passageways for reinforcing the first intersection.
  • the present invention provides a method for production of a bifurcated stent comprising the step of connecting a first stent section to a second stent section, the first stent section having an end thereof adapted for connection to an opening disposed along the length of a second stent section.
  • the present invention provides a method for production of a bifurcated stent comprising the steps of:
  • the present invention provides a method for production of a bifurcated stent comprising the steps of: passing a first stent section having a first opening disposed along a length thereof through a second stent section having a second opening disposed along a length thereof, the first stent section having a diameter less than a diameter of the second stent section; passing a leading end of the first stent section through the second opening of the second stent section; and substantially aligning the first opening and the second opening with respect to one another.
  • the present invention provides a method for delivery to a target body passageway of an expandable bifurcated stent comprising a proximal end and a distal end in communication with one another, the proximal end comprising a primary passageway and the distal end comprising a pair of secondary passageways, the stent being expandable from a first, contracted position to a second, expanded position upon the application of a radially outward force exerted on the stent, each of the primary passageway and the secondary passageway being constructed of a tubular wall having a porous surface, the method comprising the steps of: disposing the stent in the first, contracted position on a catheter; inserting the stent and catheter within the target body passageway by catheterization of the target body passageway; exerting a radially outward expansive force on the stent such that the stent assumes the second, expanded position and is urged against the target body passageway.
  • an aspect of the present invention relates to the provision of an expandable bifurcated stent constructed of a tubular wall having a porous surface.
  • tubular wall when used in relation to a stent, is intended to mean a substantially cylindrical tube which subsequently has been subjected to an etching (e.g. by laser, chemical or other suitable means) or similar technique to remove pre-selected portions of the cylindrical tube thereby providing a porous surface on the tube - this is distinct from a stent constructed of wire bent to a selected shape/design.
  • an expandable bifurcated stent having such a tubular wall has heretofore been unknown.
  • the term "bifurcated stent" is intended to have a broad meaning and encompasses any stent having a primary passageway to which is connected at least two secondary passageways. Thus, trifurcated stents are encompassed herein. Further, one of the secondary passageways can be a continuation of the primary passageway with the result that the other secondary passageway is essentially a side branch to the primary passageway.
  • the repeating pattern is a polygon having a pair of side walls substantially parallel to the longitudinal axis of the stent passageway in question, a first concave-shaped wall and a second convex-shaped wall connecting the side walls.
  • the present bifurcated stent may be constructed from any suitable starting material.
  • the starting material is a thin tube of a metal or alloy (non-limiting examples include stainless steel, titanium, tantalum, nitinol, Elgiloy, NP35N and mixtures thereof) which would then have sections thereof cut or etched out to leave a repeating pattern, inter alia, such as one or more of those disclosed in the Divysio patent applications.
  • the stent of the present invention may further comprise a coating material thereon.
  • the coating material may be disposed continuously or discontinuously on the surface of the stent. Further, the coating may be disposed on the interior and/or the exterior surf ⁇ ce(s) of the stent.
  • the coating material may be one or more of a biologically inert material (e.g. to reduce the thrombogenicity of the stent), a medicinal composition which leaches into the wall of the body passageway after implantation (e.g. to provide anticoagulant action, to deliver a pharmaceutical to the body passageway and the like) and the like.
  • the stent is preferably provided with a biocompatible coating, in order to minimize adverse interaction with the walls of the body vessel and/or with the liquid, usually blood, flowing through the vessel.
  • the coating is preferably a polymeric material, which is generally provided by applying to the stent a solution or dispersion of preformed polymer in a solvent and removing the solvent. Non-polymeric coating mate ⁇ al may alternatively be used.
  • Suitable coating materials may be polytetraflouroethylene or silicone rubbers, or polyurethanes which are known to be biocompatible.
  • the polymer has zwitterionic pendant groups, generally ammonium phosphate ester groups, for instance phosphoryl choline groups or analogues thereof.
  • suitable polymers are described in published International patent applications WO-A-93/ 16479 and WO-A-93/ 15775. Polymers described in those specifications are hemo-compatible as well as generally biocompatible and, in addition, are lubricious. When a biocompatible coating is used, It is important to ensure that the surfaces of the stent are completely coated in order to minimize unfavourable interactions, for instance with blood, which might lead to thrombosis.
  • This good coating can be achieved by suitable selection of coating conditions, such as coating solution viscosity, coating technique and/or solvent removal step.
  • Figure 1 illustrates a side elevation of a bifurcated stent in accordance with the present invention
  • Figures 2-4 illustrate a first embodiment of a method for production of a bifurcated stent
  • Figure 5 illustrates a second embodiment of a method for production of a bifurcated stent
  • Figures 6a and 6b illustrate a post-treatment of a bifurcated stent which has been produced according to the methods illustrated in Figures 2-5;
  • Figures 7 and 8 illustrate a third embodiment of a method for production of a bifurcated stent
  • Figure 9 illustrates a post-treated bifurcated stent which has been produced according to the method illustrated in Figures 7 and 8;
  • Figures 10 and 11 illustrate a fourth embodiment of a method for production of a bifurcated stent
  • Figure 12 illustrates a cross-section of a bifurcated body passageway into which the a bifurcated stent produced according to the present method of manufacture is being delivered;
  • Figure 13 illustrates a cross-section of a bifurcated body passageway in which the bifurcated stent is positioned in a first, contracted position
  • Figure 14 illustrates a cross-section of a bifurcated body passageway in which the bifurcated stent is positioned in a second, expanded position
  • FIGS. 15 and 16 illustrate a side elevation of another bifurcated stent in accordance with the present invention
  • Figures 17-22 illustrate various preferred features of the bifurcated stent illustrated in Figures 15 and 16.
  • Stent 10 comprises a proximal end 15 and a distal end 20.
  • Proximal end 15 comprises a primary passageway 25.
  • Distal end 20 comprises a pair of secondary passageways 30,35. Secondary passageways 30,35 are connected to primary passageway 25 at an intersection point 40.
  • stent 10 inco ⁇ orates the porous surface design illustrated in copending Canadian patent application number 2,134,944, referred to above. As discussed above, this design may be varied to inco ⁇ orate other designs such as those disclosed in the other Divysio patent applications.
  • a first stent section 45 comprises a cylindrical tube having a bevelled cut 50 made adjacent one end of the cylindrical tube.
  • bevelled cut 50 may be inco ⁇ orated into first stent section 45 during or after the production of first stent section 45.
  • first stent section 45 without bevelled cut 50 and thereafter use a precision jig or other means to cut first stent section 45 to produce bevelled cut 50.
  • second stent section 55 is provided and includes radial cuts
  • Radial cuts 56,57 and longitudinal cuts 58 may be produced in second stent section 55 in the manner discussed in the previous paragraph with respect to the production of bevelled cut 50 in first stent section 45. Thereafter, a flap portion 51 of first stent section 45 is folded away from bevelled cut 50. Similarly, a pair of flap 52,53 are folded away from longitudinal cut 58 to expose an opening 54. First stent section 45 is then lowered to cover opening 54 of second stent section 55. Flaps 52,53 are folded to overlap a portion of first stent section 45. Flap 51 is folded to overlap a portion of second stent section 55.
  • flaps 52,53 of second stent section 55 it is particularly preferred to adapt the geometry of flaps 52,53 of second stent section 55 such that various of the struts disposed in flaps 52,53 overlap with or are juxtaposed (in plan view) along at least a portion of the length thereof with the struts on first stent section 45 (this is illustrated in more detail hereinbelow with reference to Figure 16).
  • the degree of such overlap or juxtaposition is sufficient to:
  • the flaps may be secured to the respective stent sections by any suitable means such as spot welding (e.g. by a laser or other suitable means), loops, clips and the like.
  • spot welding e.g. by a laser or other suitable means
  • the preferred method of affixing the flaps to the respective stent section is to spot weld them.
  • intersection point 40 Figure 1 - overlapping flaps not illustrated for clarity
  • intersection point 40 Figure 1 - overlapping flaps not illustrated for clarity
  • flaps 52,53 it may be possible and even desirable to reduce the size of or even eliminate flap 51. Further, in certain circumstances, it may be possible or ever desirable to trim one or both of flaps 52,53 prior to connection of first stent section 45 to second stent section 55.
  • FIG. 5 there is illustrated another embodiment of the present method for manufacture of a bifurcated stent.
  • flap 51 ( Figures 2 and 3) is simply cut away from first stent section 45a.
  • an oval opening 54a is cut into second stent section 55a (i.e. there are no flaps affixed to second stent section 55a).
  • Stent section 45a is then lowered on and connected to second stent section 55a.
  • First stent section 45a and second stent section 55a may be connected to another in the manner described hereinabove with reference to Figure 2-4.
  • FIG. 6a there is illustrated the stent produced by the methods illustrated in Figures 2-5.
  • the result of such post-production treatment of the stent is illustrated in Figure 6b.
  • FIG. 7 and 8 there is illustrated yet another embodiment of the present method for manufacture of a bifurcated stent.
  • a pair of first stent sections 45b are secured or affixed to one another. Thereafter, an apex portion 46b of the resulting construction is removed exposing an opening 54b.
  • a second stent section 55b is then connected to opening 54b provided by the combination of first stent sections 45b.
  • the manner of securing second stent section 55b to the periphery of opening 54b created by first stent sections 45b is not particularly restricted and may be effected as discussed hereinabove.
  • first stent sections 45b and second stent section 55b are subjected to application of gentle squeezing or other sufficient force in the direction of arrows B to facilitate catheterization of the stent.
  • a first stent section 45c is provided with an opening 54c.
  • a second stent section 55c is provided with an opening 56c.
  • Second stent section 55c has a diameter slightly less than that of first stent section 45c. The difference in diameter ⁇ between first stent section 45c and second stent section 55c is sufficient to enable coaxial movement of the stent sections with respect to one another with causing damage to either stent section.
  • Second stent section 55c is pulled through opening 54c until opening 56c is aligned with opening 54c - this is illustrated by dashed oval E in Figure 11.
  • region F ( Figure 11) of the resulting bifurcated stent is "double reinforced" since it contains a coaxial disposition of first stent section 45c and second stent section 55c. Accordingly, it is possible and, in some cases even desirable, to modify the design of the respective stent sections in this region so that the overall expansion and relative flexibility /rigidity of the stent in this region is commensurate with that of the remaining portion of the stent (i.e. the secondary passageways which branch off from region F in Figure 11).
  • first stent section 45c or second stent section 55c may be shortened thereby minimizing the size of region F in Figure 11.
  • bifurcated body passageway 150 comprised of a proximal passageway 155 and a pair of distal passageways 160,165.
  • bifurcated body passageway 150 comprises a Type "D" Bifurcation lesion having characteristic blockages 170,175,180.
  • Stent 10 is delivered to bifurcated body passageway 150 in the following manner. Initially, a pair of guidewires 185,190 are inserted into proximal passageway 155 such that guidewire 185 enters distal passageway 160 and guidewire 190 enters distal passageway 165. The manner by which the guidewires are inserted is conventional and within the purview of a person skilled in the art. As illustrated, stent 10 is positioned in association with a pair of catheters 195,200 (for clarity, the interior of stent 10 is not shown). Catheter 195 has associated with it a balloon 205. Catheter 200 has associated with it a balloon 210. Balloons 205,210 substantially fill primary passageway 25 of stent 10. Balloon 205 substantially fills secondary passageway 30 of stent 10. Balloon 210 substantially fills secondary passageway 35 of stent 10.
  • the stent/catheter/balloon combination is delivered through proximal passageway 155 with the aid of guidewires 185,190.
  • predisposition of guidewires 185,190 serves to separate secondary passageways 30,35 to be disposed in distal passageways 160,165, respectively.
  • stent 10 is positioned in place.
  • balloons 205,210 are expanded resulting in implantation of stent 10 in the corresponding interior surfaces of proximal passageway 155 and distal passageways 160,165.
  • balloons 205,210 are collapsed.
  • catheters 195,200 and guidewires 185,190 have been removed leaving the implanted stent 10 shown in Figure 14.
  • blockages 170,175,180 are bulged radially outwardly in combination with the appropriate portions of proximal passageway 155 and distal passageways 160,165 resulting in a reduction in the overall blockage in bifurcated body passage 150.
  • implantation of stent 10 can be accomplished by various other means.
  • the balloon and guidewire would be design to mimic the bifurcated design of the stent.
  • the stent can be made of a suitable material which will expand when bifurcated body passageway 150 is flushed with a liquid having an elevated temperature (e.g. 150°F-160°F).
  • stent 10 can be designed to expand upon the application of mechanical forces other than those applied by a balloon/catheter. Still further, stent 10 can be designed self-expanding (e.g. by constructing stent from material such as nitinol and the like) to be implanted as described above. In this embodiment, the radially outward force exerted on the stent would be generated within the stent itself.
  • FIG. 15-22 there is illustrated another preferred bifurcated stent in accordance with the present invention.
  • the stent illustrated in Figures 15-22 shares many of the features of stent 10 illustrated in Figure 1.
  • Figures 15 and 16 there is illustrated a stent
  • FIG. 15 is a side elevation of stent 100 without the porous surface illustrated (for clarity).
  • Figure 16 is a side elevation of an enlarged portion of stent 100 with the porous surface illustrated.
  • Stent 100 comprises a proximal end 102 and a distal end 104.
  • Proximal end 102 comprises a primary passageway 103.
  • Distal end 104 comprises a pair of secondary passageways 105, 106.
  • Secondary passageways 105,106 are connected to primary passageway 103 at an intersection point 107 - the nature of intersection point 107 will be further discussed hereinbelow. It is intersection point 107 which distinguishes stent 100 in Figure 16 from stent 10 in Figure 1.
  • stent 100 inco ⁇ orates the porous surface design illustrated in copending Canadian patent application number 2,134,944, referred to above. As discussed above, this design may be varied to inco ⁇ orate other designs such as those disclosed in the other Divysio patent applications.
  • manufacture of stent 100 will be discussed.
  • manufacture of stent 100 is similar to the manufacture of stent 10 illustrated in Figures 1-4 and discussed hereinabove.
  • the principle difference in the manufacture of stent 100 is the use of a modified first stent section 108.
  • First stent section 108 is constructed from a substantially cylindrical tube 109.
  • a porous surface 110 is disposed on a major portion of cylindrical tube 109.
  • a first connection tab 111 and a second connection tab 112 are also disposed on cylindrical tube 109.
  • first section 108 comprising porous 110, first connection tab 111 and second connection tab 112 using computer programmable, high precision laser etching techniques or by other etching techniques in combination with precision jig techniques. This results in an end of porous surface 110 comprising first connection tab 111 , second connection tab 112 and a bevelled edge 113.
  • the product of the cutting techniques is illustrated in Figure 18.
  • Figure 19 is an enlarged perspective view of a portion of first connection tab 111 (second connection tab 112 is preferably the same).
  • first connection tab 111 comprises a stem 114 and a head 115.
  • stem 114 and/or head 115 are curved to have a shape complementary to the outer surface of the second section to which first stent section 108 is connected (discussed in more detailed hereinbelow).
  • Stem 114 and head 115 comprise a plurality of slots 116 disposed therein. Slots 116 may be disposed in stem 114 and head 115 by the use of a computer programmable, high precision laser as described above.
  • slots 116 are disposed throughout the thickness of stem 114 and head 115.
  • Slots 116 may be may have a straight or tapered cross-section. Preferably, slots 116 have a thickness in the range of from about 0.0015 to about 0.004 inches. Head 115 further comprises solid (i.e. , slot-free or non- porous) regions 117,118.
  • slots 116 serve to from a porous surface in first connection tab 111 (second connection tab 112 is preferably the same). While it is preferred to have such a porous surface disposed in the connection tabs, the precise nature of the porosity is not particularly restricted. The provision of a porous surface, particularly at head 115, facilitates expansion of the connection tab while minimizing or avoiding the occurrence of cracking or distortion.
  • first connection tab 111 and second connection tab 112 are bent or otherwise moved to be substantially collinear with the periphery of bevelled edge 113 (i.e., as illustrated in Figure 118).
  • first stent section 108 may be connected to another stent section of a design similar to second stent section 55 discussed hereinabove with reference to Figures 2-4 - see intersection point 107 in Figure 16.
  • First connection tab 111 and second connection tab 112 may be secured to the second stent section as described above. Specifically, it is particularly preferred to connect solid (i.e. , non-porous) regions 117,118 to the stent section portion.
  • the provision of at least one solid (i.e., non-porous) region in the connection tabs facilitates attachment of the respective stent sections to one another (e.g., laser welding is facilitated significantly);
  • connection tabs facilitates bending thereof for connection of the respective stent sections
  • slots 116 particularly in second connection tab 112 (see Figure 15) allows the slots to function as a solid state valve at the "crotch" of the bifurcated stent thereby providing sealed, reinforcement of the bifurcated stent in this crucial region - this is illustrated in Figure 20 which depicts tapered openings for slots 116 in the apex of the bend in stem 114.
  • Figure 21 illustrates an alternate embodiment of the embodiment illustrated in Figures 15-20.
  • second stent section 55 otherwise the same as that described hereinabove with reference to Figures 1-4, is adapted to include a landing 119 for receiving a solid (i.e. non-slot or non- porous) connection tab 120.
  • Landing 119 may be connected to connection tab 120 as described hereinabove.
  • connection tab 121 having the entire surface thereof slotted and otherwise porous is connected to landing 119.
  • connection tab 111 and second connection tab 112 have been illustrated as being attached to first stent portion 108, it is possible to have these tabs integral with second stent portion 55.
  • the connection tabs do not have to integral with either of the stent portions and, instead, can be custom-designed, independent connection tabs which are affixed to both stent portions.
  • the connection tabs integral or independent

Abstract

An expandable bifurcated stent comprising a proximal end and a distal end in communication with one another. The proximal end comprises a primary passageway and the distal end comprises a pair of secondary passageways. The stent is expandable from a first, contracted position to a second, expanded position upon the application of a radially outward force exerted on the stent. Each of the primary passageway and the secondary passageway being constructed has a porous surface. A method for production of a bifurcated stent is also described. Preferably, the method comprises the step of connecting a first stent section to a second stent section, the first stent section having an end thereof adapted for connection to an opening disposed along the length of a second stent section.

Description

BI FURCATED STENT AND METHOD FOR THE MANUFACTURE OF SAME
TECHNICAL FTELD The present invention relates to a bifurcated stent and to a method for the manufacture and delivery of a bifurcated stent.
BACKGROUND ART
Stents are generally known. Indeed, the term "stent" has been used interchangeably with terms such as "intraluminal vascular graft" and "expansible prosthesis". As used throughout this specification the term "stent" is intended to have a broad meaning and encompasses any expandable prosthetic device for implantation in a body passageway (e.g., a lumen or artery).
In the past six to eight years, the use of stents has attracted an increasing amount of attention due the potential of these devices to be used, in certain cases, as an alternative to surgery. Generally, a stent is used to obtain and maintain the patency of the body passageway while maintaining the integrity of the passageway. As used in this specification, the term "body passageway" is intended to have a broad meaning and encompasses any duct (e.g. , natural or iatrogenic) within the human body and can include a member selected from the group comprising: blood vessels, respiratory ducts, gastrointestinal ducts and the like.
Initial stents were self-expanding, spring-like devices which were inserted in the body passageway in a contracted state. When released, the stent would automatically expand and increase to a final diameter dependent on the size of the stent and the elasticity of the body passageway. Such stents are known in the art as the Wallstent™.
The self-expanding stents were found by some investigators to be deficient since, when deployed, they could place undue, permanent stress on the walls of the body passageway. This lead to the development of various stents which were controllably expandable at the target body passageway so that only sufficient force to maintain the patency of the body passageway was applied in expanding the stent.
Generally, in these later systems, a stent, in association with a balloon, is delivered to the target area of the body passageway by a catheter system. Once the stent has been properly located (the target area of the body passageway can be filled with a contrast medium to facilitate visualization during fluoroscopy), the balloon is expanded thereby expanding the stent, e.g. by plastic deformation of the stent structure, so that the latter is urged in place against the body passageway. As indicated above, the amount of force applied is at least that necessary to maintain the patency of the body passageway. At this point, the balloon is deflated and withdrawn within the catheter, and subsequently removed. Ideally, the stent will remain in place and maintain the target area of the body passageway substantially free of blockage (or narrowing). A stent which has gained some notoriety in the art is known as the
Palmaz-Schatz™ Balloon Expandable Stent (hereinafter referred to as "the Palmaz-Schatz stent"). This stent is discussed in a number of patents including United States patents 4,733,665, 4,739,762, 5,102,417 and 5,316,023, the contents of each of which are hereby incoφorated by reference. Another stent which has gained some notoriety in the art is known as
Gianturco-Roubin Flex-Stent™ (hereinafter referred to as "the Gianturco- Roubin stent"). This stent is discussed in a number of patents including United States patents 4,800,882, 4,907,336 and 5,041,126, the contents of each of which are hereby incorporated by reference. Other types of stents are disclosed in the following patents:
United States patent 5,035,706 (Gianturco et al.), United States patent 5,037,392 (Hillstead), United States patent 5,147,385 (Beck et al.), United States patent 5,282,824 (Gianturco),
Canadian patent 1 ,239,755 (Wallsten), and Canadian patent 1 ,245,527 (Gianturco et al.),
the contents of each of which are hereby incorporated by reference.
All of the stents described in the above-identified patents share the common design of being mono-tubular and thus, are best suited to be delivered and implanted in-line in the body passageway. These known stents are inappropriate for use in a bifurcated body passageway (e.g. a body passageway comprising a parent passageway that splits into a pair of passageways). Further, these stents are inappropriate for use in a body passageway having side branches since: (i) accurate placement of the stent substantially increases the risk to the patient, (ii) the risk of passageway closure in the side branches is increased, and (iii) the side branches will be substantially inaccessible.
Indeed the Physician Guide published in support of the Palmaz-Schatz stent states on page 32 (the contents of which are hereby incoφorated by reference):
" ... no attempt should be made following placement of a PALMAZ-SCHATZ stent to access the side branch with a guide wire or a balloon, as such attempts may result in additional damage to the target vessel or the stent. Attempts to treat obstructed side branches within stented segments can result in balloon entrapment, necessitating emergency bypass surgery. "
Thus, when installed, the Palmaz-Schatz stent admittedly shields side branches emanating from the target area of the body passageway effectively permanently.
This can be problematic since the only way to treat blockage or other problems associated with the side branches is to perform the type of surgery which installation of the stent was intended to avoid.
This contraindication for conventional mono-tubular stents is corroborated by a number of investigators. See, for example, the following: 1. Interventional Cardiovascular Medicine: Principles and Practice (1994); Publisher: Churchill Livingstone Inc. ; pages 221-223 (Ohman et al.), 487-488 (Labinaz et al.), 667-668 (Bashore et al.) and 897 (Bailey et al.), including references cited therein;
2. Gianturco-Roubin Flex-Stent™ Coronary Stent: Physician's Guide; page 2, Paragraph 3 under WARNINGS;
3. Circulation, Vol. 83, No. 1 , January 1991 (Schatz et al.); entitled "Clinical Experience With the Palmaz- Schatz Coronary Stent"; pages 148-161 at page 149; and
4. American Heart Journal, Vol. 127, No. 2, February
1994 (Eeckhout et al.); entitled "Complications and follow-up after intracoronary stenting: Critical analysis of a 6-year single-center experience" ; pages 262-272 at page 263,
the contents of each of which are hereby incoφorated by reference.
Further, some investigators have attempted to install individual stents in each branch of the bifurcated body passageway. However, this approach is fraught with at least two significant problems. First, implantation of three individual stents, together with the expansive forces generated upon implantation results in subjecting the central walls of the bifurcated body passageway to undue stress which may lead to post-procedural complications. Second, since the central walls of the bifurcated body passageway are not supported by the individual stents, this area of the passageway is left substantially unprotected and susceptible to blockage. One particular problem area with bifurcated body passageways is the occurrence of bifurcation lesions within the coronary circulation. Generally, these legions may be classified as follows:
Type Characteristic
A Prebranch stenosis not involving the ostium of the side branch;
B Postbranch stenosis of the parent vessel not involving the origin of the side branch;
C Stenosis encompassing the side branch but not involving the ostium;
D Stenosis involving the parent vessel and ostium of the side branch;
E Stenosis involving the ostium of the side branch only; and
F Stenosis discretely involving the parent vessel and ostium of the side branch.
See Atlas of Interventional Cardiology (Popma et al.), 1994, pages 77-79, the contents of which are hereby incoφorated by reference. The presence of bifurcation lesions is predictive of increased procedural complications including acute vessel closure.
Detailed classification of other bifurcated body passageways is relatively undeveloped given the lack of non-surgical treatment approaches. United States patent 4,994,071 (MacGregor) discloses a bifurcating stent apparatus. The particular design incoφorates a series of generally parallel oriented loops interconnected by a sequence of "half-birch" connections. The lattice structure of the illustrated stent is constructed of wire. The use of such wire is important to obtain the loop structure of the illustrated design. The use of a wire loop construction is disadvantageous since it is complicated to manufacture and the resulting stent is subject to expansion variability (e.g. variable post-expansion distortion and the like).
United States patents 3,993,078 (Bergentz et al.) and 5,342,387 (Summers) also disclose and illustrate a bifurcated stent design constructed of wire. These designs suffer from the same disadvantages as the design described in the previous paragraph.
It would be desirable to have a reliable, expandable bifurcated stent since this would be useful in treating aneurysms, blockages and other ailments. It would be further desirable to have a practical method for producing such a stent. It would also be desirable if such a stent was relatively easy to install.
DISCLOSURE OF THE INVENTION
It is an object of the present invention to provide a novel expandable bifurcated stent which obviates or mitigates at least one of the above-mentioned disadvantages of the prior art.
It is another object of the present invention to provide a novel method for the manufacture of an expandable bifurcated stent.
It is another object of the present invention to provide a novel method for implanting an expandable bifurcated stent.
Accordingly, in one of its aspects, the present invention provides an expandable bifurcated stent comprising a proximal end and a distal end in communication with one another, the proximal end comprising a primary passageway and the distal end comprising a pair of secondary passageways, each secondary passageway in communication with the primary passageway at a first intersection, the stent being expandable from a first, contracted position to a second, expanded position upon the application of a radially outward force exerted on the stent, each of the primary passageway and the secondary passageways being constructed of a tubular wall having a porous surface, at least one connection portion being disposed at the first intersection for reinforcing the first intersection.
In another of its aspects, the present invention provides expandable bifurcated stent comprising a proximal end and a distal end in communication with one another, the proximal end comprising a primary passageway and the distal end comprising a pair of secondary passageways, each secondary passageway in communication with the primary passageway at a first intersection, the stent being expandable from a first, contracted position to a second, expanded position upon the application of a radially outward force exerted on the stent, each of the primary passageway and the secondary passageways having a porous surface, at least one connection portion interconnecting the pair of secondary passageways for reinforcing the first intersection.
In yet another of its aspects, the present invention provides a method for production of a bifurcated stent comprising the step of connecting a first stent section to a second stent section, the first stent section having an end thereof adapted for connection to an opening disposed along the length of a second stent section.
In yet another of its aspects, the present invention provides a method for production of a bifurcated stent comprising the steps of:
(i) connecting a first stent section to a second stent section to provide a connection portion;
(ii) provide an opening in the connection portion; (iii) connecting a third stent section to the connection portion. In yet another of its aspects, the present invention provides a method for production of a bifurcated stent comprising the steps of: passing a first stent section having a first opening disposed along a length thereof through a second stent section having a second opening disposed along a length thereof, the first stent section having a diameter less than a diameter of the second stent section; passing a leading end of the first stent section through the second opening of the second stent section; and substantially aligning the first opening and the second opening with respect to one another.
In yet another of its aspects, the present invention provides a method for delivery to a target body passageway of an expandable bifurcated stent comprising a proximal end and a distal end in communication with one another, the proximal end comprising a primary passageway and the distal end comprising a pair of secondary passageways, the stent being expandable from a first, contracted position to a second, expanded position upon the application of a radially outward force exerted on the stent, each of the primary passageway and the secondary passageway being constructed of a tubular wall having a porous surface, the method comprising the steps of: disposing the stent in the first, contracted position on a catheter; inserting the stent and catheter within the target body passageway by catheterization of the target body passageway; exerting a radially outward expansive force on the stent such that the stent assumes the second, expanded position and is urged against the target body passageway.
Thus, an aspect of the present invention relates to the provision of an expandable bifurcated stent constructed of a tubular wall having a porous surface. As used throughout this specification, the term "tubular wall", when used in relation to a stent, is intended to mean a substantially cylindrical tube which subsequently has been subjected to an etching (e.g. by laser, chemical or other suitable means) or similar technique to remove pre-selected portions of the cylindrical tube thereby providing a porous surface on the tube - this is distinct from a stent constructed of wire bent to a selected shape/design. To the knowledge of the Applicant's, an expandable bifurcated stent having such a tubular wall has heretofore been unknown. As used throughout this specification, the term "bifurcated stent" is intended to have a broad meaning and encompasses any stent having a primary passageway to which is connected at least two secondary passageways. Thus, trifurcated stents are encompassed herein. Further, one of the secondary passageways can be a continuation of the primary passageway with the result that the other secondary passageway is essentially a side branch to the primary passageway.
The Applicant's have also discovered that various repeating patterns in the porous surface of the tubular wall are particularly advantageous. Generally, the repeating pattern is a polygon having a pair of side walls substantially parallel to the longitudinal axis of the stent passageway in question, a first concave-shaped wall and a second convex-shaped wall connecting the side walls. The various repeating patterns which are useful in the context of the present invention are disclosed in the following copending patent applications filed in the name of the assignee of the present invention:
Canadian patent application number 2,134,997 (filed November 3, 1994); Canadian patent application number 2,171,047 (filed March 5, 1996); Canadian patent application number 2,175,722 (filed May 3, 1996); Canadian patent application number 2,185,740 (filed September 17, 1996); International patent application PCT/CA97/00151 (filed March 5, 1997); and International patent application PCT/CA97/00152 (filed March 5, 1997);
the contents of each of which are hereby incoφorated by reference (hereinafter collectively referred to as the "Divysio patent applications").
The present bifurcated stent may be constructed from any suitable starting material. Preferably, the starting material is a thin tube of a metal or alloy (non-limiting examples include stainless steel, titanium, tantalum, nitinol, Elgiloy, NP35N and mixtures thereof) which would then have sections thereof cut or etched out to leave a repeating pattern, inter alia, such as one or more of those disclosed in the Divysio patent applications. The stent of the present invention may further comprise a coating material thereon. The coating material may be disposed continuously or discontinuously on the surface of the stent. Further, the coating may be disposed on the interior and/or the exterior surføce(s) of the stent. The coating material may be one or more of a biologically inert material (e.g. to reduce the thrombogenicity of the stent), a medicinal composition which leaches into the wall of the body passageway after implantation (e.g. to provide anticoagulant action, to deliver a pharmaceutical to the body passageway and the like) and the like. The stent is preferably provided with a biocompatible coating, in order to minimize adverse interaction with the walls of the body vessel and/or with the liquid, usually blood, flowing through the vessel. The coating is preferably a polymeric material, which is generally provided by applying to the stent a solution or dispersion of preformed polymer in a solvent and removing the solvent. Non-polymeric coating mateπal may alternatively be used. Suitable coating materials, for instance polymers, may be polytetraflouroethylene or silicone rubbers, or polyurethanes which are known to be biocompatible. Preferably, however, the polymer has zwitterionic pendant groups, generally ammonium phosphate ester groups, for instance phosphoryl choline groups or analogues thereof. Examples of suitable polymers are described in published International patent applications WO-A-93/ 16479 and WO-A-93/ 15775. Polymers described in those specifications are hemo-compatible as well as generally biocompatible and, in addition, are lubricious. When a biocompatible coating is used, It is important to ensure that the surfaces of the stent are completely coated in order to minimize unfavourable interactions, for instance with blood, which might lead to thrombosis.
This good coating can be achieved by suitable selection of coating conditions, such as coating solution viscosity, coating technique and/or solvent removal step. BRIEF DESCRIPTION OF THE DRAWINGS
Embodiments of the present invention will be described with reference to the accompanying drawings wherein like numerals designate like parts and in which: Figure 1 illustrates a side elevation of a bifurcated stent in accordance with the present invention;
Figures 2-4 illustrate a first embodiment of a method for production of a bifurcated stent;
Figure 5 illustrates a second embodiment of a method for production of a bifurcated stent;
Figures 6a and 6b illustrate a post-treatment of a bifurcated stent which has been produced according to the methods illustrated in Figures 2-5;
Figures 7 and 8 illustrate a third embodiment of a method for production of a bifurcated stent; Figure 9 illustrates a post-treated bifurcated stent which has been produced according to the method illustrated in Figures 7 and 8;
Figures 10 and 11 illustrate a fourth embodiment of a method for production of a bifurcated stent;
Figure 12 illustrates a cross-section of a bifurcated body passageway into which the a bifurcated stent produced according to the present method of manufacture is being delivered;
Figure 13 illustrates a cross-section of a bifurcated body passageway in which the bifurcated stent is positioned in a first, contracted position;
Figure 14 illustrates a cross-section of a bifurcated body passageway in which the bifurcated stent is positioned in a second, expanded position;
Figures 15 and 16 illustrate a side elevation of another bifurcated stent in accordance with the present invention;
Figures 17-22 illustrate various preferred features of the bifurcated stent illustrated in Figures 15 and 16. BEST MODE FOR CARRYING OUT THE INVENTION
With reference to Figure 1, there is illustrated a stent 10. Stent 10 comprises a proximal end 15 and a distal end 20. Proximal end 15 comprises a primary passageway 25. Distal end 20 comprises a pair of secondary passageways 30,35. Secondary passageways 30,35 are connected to primary passageway 25 at an intersection point 40.
As will be apparent to those of skill in the art, stent 10 incoφorates the porous surface design illustrated in copending Canadian patent application number 2,134,944, referred to above. As discussed above, this design may be varied to incoφorate other designs such as those disclosed in the other Divysio patent applications.
With reference to Figures 2-4, an embodiment of the present method for production of a bifurcated stent is illustrated. For ease of illustration, the porous surface of the tubular wall of the stent is not illustrated. As illustrated, a first stent section 45 comprises a cylindrical tube having a bevelled cut 50 made adjacent one end of the cylindrical tube. Those of skill in the art will recognize that bevelled cut 50 may be incoφorated into first stent section 45 during or after the production of first stent section 45. Specifically, it is possible to produce first stent section 45 having a pre-selected porous design which includes bevelled cut 50 via a computer programmable, high precision laser etching technique. Alternatively, it is possible to use another etching technique to produce first stent section 45 without bevelled cut 50 and thereafter use a precision jig or other means to cut first stent section 45 to produce bevelled cut 50. Similarly, a second stent section 55 is provided and includes radial cuts
56,57 and a longitudinal cut 58. Radial cuts 56,57 and longitudinal cuts 58 may be produced in second stent section 55 in the manner discussed in the previous paragraph with respect to the production of bevelled cut 50 in first stent section 45. Thereafter, a flap portion 51 of first stent section 45 is folded away from bevelled cut 50. Similarly, a pair of flap 52,53 are folded away from longitudinal cut 58 to expose an opening 54. First stent section 45 is then lowered to cover opening 54 of second stent section 55. Flaps 52,53 are folded to overlap a portion of first stent section 45. Flap 51 is folded to overlap a portion of second stent section 55. With reference to Figure 4, it is particularly preferred to adapt the geometry of flaps 52,53 of second stent section 55 such that various of the struts disposed in flaps 52,53 overlap with or are juxtaposed (in plan view) along at least a portion of the length thereof with the struts on first stent section 45 (this is illustrated in more detail hereinbelow with reference to Figure 16). Preferably, the degree of such overlap or juxtaposition is sufficient to:
(i) facilitate affixing the flaps 52,53 of second stent section
55 to first stent section 45; (ii) achieve uniform expansion of the stent junction without occurrence of substantial distortion; and (iii) avoid the occurrence of "stent trap" or "stent jail"
(usually the result of cracking, buckling or other distortion at the junction of a deployed bifurcated stent making difficult or impossible to deliver a further stent through the stent).
At this point, the flaps may be secured to the respective stent sections by any suitable means such as spot welding (e.g. by a laser or other suitable means), loops, clips and the like. The preferred method of affixing the flaps to the respective stent section is to spot weld them. A particular advantage of the process illustrated in Figures 2-4 is that intersection point 40 (Figure 1 - overlapping flaps not illustrated for clarity) of the resulting stent is reinforced by virtue of disposition of the flaps overlapping a portion of the respective stent sections.
As will be apparent to those of skill in the art, in certain circumstances, it may be possible and even desirable to reduce the size of or even eliminate flap 51. Further, in certain circumstances, it may be possible or ever desirable to trim one or both of flaps 52,53 prior to connection of first stent section 45 to second stent section 55.
With reference to Figure 5, there is illustrated another embodiment of the present method for manufacture of a bifurcated stent. In this embodiment, flap 51 (Figures 2 and 3) is simply cut away from first stent section 45a. Further, an oval opening 54a is cut into second stent section 55a (i.e. there are no flaps affixed to second stent section 55a). Stent section 45a is then lowered on and connected to second stent section 55a. First stent section 45a and second stent section 55a may be connected to another in the manner described hereinabove with reference to Figure 2-4.
With reference to Figure 6a, there is illustrated the stent produced by the methods illustrated in Figures 2-5. During production of the stent, it is desirable to minimize the angle between first stent section 45 and second stent section 55. Even with this effort, it is preferred that the adjacent termini of first stent section 45 and section stent section 55 are subjected to application of gentle squeezing or other sufficient force in the direction of arrows A to facilitate catheterization of the stent. The result of such post-production treatment of the stent is illustrated in Figure 6b.
With reference to Figures 7 and 8, there is illustrated yet another embodiment of the present method for manufacture of a bifurcated stent. In this embodiment, a pair of first stent sections 45b are secured or affixed to one another. Thereafter, an apex portion 46b of the resulting construction is removed exposing an opening 54b. A second stent section 55b is then connected to opening 54b provided by the combination of first stent sections 45b. The manner of securing second stent section 55b to the periphery of opening 54b created by first stent sections 45b is not particularly restricted and may be effected as discussed hereinabove. As will be appreciated by those of skill in the art, it is possible and, in certain circumstances, desirable, to have one or more flaps on one or move of first stent sections 45b and second stent section 55b. Such flaps would be used in the manner discussed hereinabove in respect of Figures 2-4 to overlap a portion of the opposite stent section. With reference to Figure 9, there is illustrated the stent produced according to the method illustrated in Figures 7 and 8 after post-treatment in the manner discussed above in respect of Figures 6a and 6b. That is, first stent sections 45b are subjected to application of gentle squeezing or other sufficient force in the direction of arrows B to facilitate catheterization of the stent.
With reference to Figures 10 and 11, there is illustrated yet another embodiment of the present method for manufacture of a bifurcated stent. In this embodiment, a first stent section 45c is provided with an opening 54c. A second stent section 55c is provided with an opening 56c. Second stent section 55c has a diameter slightly less than that of first stent section 45c. The difference in diameter^ between first stent section 45c and second stent section 55c is sufficient to enable coaxial movement of the stent sections with respect to one another with causing damage to either stent section.
As illustrated by arrow C in Figure 10, the end of second stent section 55c is coaxially fed into an end of first stent section 45c. Once the leading end of second stent section 55c reaches opening 54c of first stent section 45c, it is pulled through opening 54c as illustrated by arrow D in Figure 10. Second stent section 55c is pulled through opening 54c until opening 56c is aligned with opening 54c - this is illustrated by dashed oval E in Figure 11. When practising the method illustrated in Figures 10 and 11 , care should be taken to design openings 54c and 56c so that they are in alignment when the trailing end of second stent section 55c is flush with the trailing end of first stent section 45c. Further, region F (Figure 11) of the resulting bifurcated stent is "double reinforced" since it contains a coaxial disposition of first stent section 45c and second stent section 55c. Accordingly, it is possible and, in some cases even desirable, to modify the design of the respective stent sections in this region so that the overall expansion and relative flexibility /rigidity of the stent in this region is commensurate with that of the remaining portion of the stent (i.e. the secondary passageways which branch off from region F in Figure 11). While the embodiment illustrated in Figures 10 and 11 illustrates the resultant bifurcated stent having a coaxial, overlapping arrangement of stent sections flush at one end, it will be appreciated by those of skill in the art that the length of first stent section 45c or second stent section 55c may be shortened thereby minimizing the size of region F in Figure 11.
With reference to Figures 12-14 , there is illustrated a bifurcated body passageway 150 comprised of a proximal passageway 155 and a pair of distal passageways 160,165. As illustrated, bifurcated body passageway 150 comprises a Type "D" Bifurcation lesion having characteristic blockages 170,175,180.
Stent 10 is delivered to bifurcated body passageway 150 in the following manner. Initially, a pair of guidewires 185,190 are inserted into proximal passageway 155 such that guidewire 185 enters distal passageway 160 and guidewire 190 enters distal passageway 165. The manner by which the guidewires are inserted is conventional and within the purview of a person skilled in the art. As illustrated, stent 10 is positioned in association with a pair of catheters 195,200 (for clarity, the interior of stent 10 is not shown). Catheter 195 has associated with it a balloon 205. Catheter 200 has associated with it a balloon 210. Balloons 205,210 substantially fill primary passageway 25 of stent 10. Balloon 205 substantially fills secondary passageway 30 of stent 10. Balloon 210 substantially fills secondary passageway 35 of stent 10.
The stent/catheter/balloon combination is delivered through proximal passageway 155 with the aid of guidewires 185,190. As the stent/catheter/balloon combination approaches distal passageways 160,165, predisposition of guidewires 185,190 serves to separate secondary passageways 30,35 to be disposed in distal passageways 160,165, respectively. Thus, as illustrated in Figure 13, stent 10 is positioned in place.
Once stent 10 is in position, balloons 205,210 are expanded resulting in implantation of stent 10 in the corresponding interior surfaces of proximal passageway 155 and distal passageways 160,165. Upon implantation of stent 10, balloons 205,210 are collapsed. Thereafter, catheters 195,200 and guidewires 185,190 have been removed leaving the implanted stent 10 shown in Figure 14. As illustrated in Figure 14, blockages 170,175,180 are bulged radially outwardly in combination with the appropriate portions of proximal passageway 155 and distal passageways 160,165 resulting in a reduction in the overall blockage in bifurcated body passage 150.
It will be apparent to those of skill in the art that implantation of stent 10 can be accomplished by various other means. For example, it is contemplated that it is possible to substitute the pair of catheter/balloon combinations illustrated in Figures 12 and 13 with a single, bifurcated catheter/balloon design which mimics the design of the stent. Thus, in this modification, the balloon and guidewire would be design to mimic the bifurcated design of the stent. As further alternative, it is contemplated that the stent can be made of a suitable material which will expand when bifurcated body passageway 150 is flushed with a liquid having an elevated temperature (e.g. 150°F-160°F). Further, stent 10 can be designed to expand upon the application of mechanical forces other than those applied by a balloon/catheter. Still further, stent 10 can be designed self-expanding (e.g. by constructing stent from material such as nitinol and the like) to be implanted as described above. In this embodiment, the radially outward force exerted on the stent would be generated within the stent itself.
With reference to Figures 15-22, there is illustrated another preferred bifurcated stent in accordance with the present invention. As will be apparent to those of skill in the art, the stent illustrated in Figures 15-22 shares many of the features of stent 10 illustrated in Figure 1. Thus, with reference to Figures 15 and 16, there is illustrated a stent
100. Figure 15 is a side elevation of stent 100 without the porous surface illustrated (for clarity). Figure 16 is a side elevation of an enlarged portion of stent 100 with the porous surface illustrated. Stent 100 comprises a proximal end 102 and a distal end 104. Proximal end 102 comprises a primary passageway 103. Distal end 104 comprises a pair of secondary passageways 105, 106. Secondary passageways 105,106 are connected to primary passageway 103 at an intersection point 107 - the nature of intersection point 107 will be further discussed hereinbelow. It is intersection point 107 which distinguishes stent 100 in Figure 16 from stent 10 in Figure 1.
As will be apparent to those of skill in the art, stent 100 incoφorates the porous surface design illustrated in copending Canadian patent application number 2,134,944, referred to above. As discussed above, this design may be varied to incoφorate other designs such as those disclosed in the other Divysio patent applications.
With reference to Figures 17-19, manufacture of stent 100 will be discussed. Generally, the manufacture of stent 100 is similar to the manufacture of stent 10 illustrated in Figures 1-4 and discussed hereinabove. The principle difference in the manufacture of stent 100 is the use of a modified first stent section 108.
First stent section 108 is constructed from a substantially cylindrical tube 109. A porous surface 110 is disposed on a major portion of cylindrical tube 109. A first connection tab 111 and a second connection tab 112 are also disposed on cylindrical tube 109. As discussed hereinabove, it is possible to produce first section 108 comprising porous 110, first connection tab 111 and second connection tab 112 using computer programmable, high precision laser etching techniques or by other etching techniques in combination with precision jig techniques. This results in an end of porous surface 110 comprising first connection tab 111 , second connection tab 112 and a bevelled edge 113. The product of the cutting techniques is illustrated in Figure 18.
Figure 19 is an enlarged perspective view of a portion of first connection tab 111 (second connection tab 112 is preferably the same). As illustrated, first connection tab 111 comprises a stem 114 and a head 115. Preferably, stem 114 and/or head 115 are curved to have a shape complementary to the outer surface of the second section to which first stent section 108 is connected (discussed in more detailed hereinbelow). Stem 114 and head 115 comprise a plurality of slots 116 disposed therein. Slots 116 may be disposed in stem 114 and head 115 by the use of a computer programmable, high precision laser as described above. Preferably, slots 116 are disposed throughout the thickness of stem 114 and head 115. Slots 116 may be may have a straight or tapered cross-section. Preferably, slots 116 have a thickness in the range of from about 0.0015 to about 0.004 inches. Head 115 further comprises solid (i.e. , slot-free or non- porous) regions 117,118.
Thus, in the embodiment illustrated in Figure 19, slots 116 serve to from a porous surface in first connection tab 111 (second connection tab 112 is preferably the same). While it is preferred to have such a porous surface disposed in the connection tabs, the precise nature of the porosity is not particularly restricted. The provision of a porous surface, particularly at head 115, facilitates expansion of the connection tab while minimizing or avoiding the occurrence of cracking or distortion.
After the production of first stent section 108, first connection tab 111 and second connection tab 112 are bent or otherwise moved to be substantially collinear with the periphery of bevelled edge 113 (i.e., as illustrated in Figure 118). At this point, first stent section 108 may be connected to another stent section of a design similar to second stent section 55 discussed hereinabove with reference to Figures 2-4 - see intersection point 107 in Figure 16. In this embodiment, as in the embodiments illustrated in Figures 2-4, it is preferred to adapt the geometry of flaps 52,53 of second stent section 55 such that various of the struts disposed in flaps 52,53 overlap along at a portion of the length thereof with the struts on first stent section 108. See, for example, regions G and H in Figure 16 which illustrates an embodiment of such partial overlap and juxtaposition (in plan view). First connection tab 111 and second connection tab 112 may be secured to the second stent section as described above. Specifically, it is particularly preferred to connect solid (i.e. , non-porous) regions 117,118 to the stent section portion.
The benefits accruing from the use of first stent section 108 in the production a bifurcated stent include: 1. The provision of at least one solid (i.e., non-porous) region in the connection tabs facilitates attachment of the respective stent sections to one another (e.g., laser welding is facilitated significantly);
2. The provision of a porous surface in at least a portion of the connection tabs facilitates bending thereof for connection of the respective stent sections; and
3. The provision of slots 116, particularly in second connection tab 112 (see Figure 15), allows the slots to function as a solid state valve at the "crotch" of the bifurcated stent thereby providing sealed, reinforcement of the bifurcated stent in this crucial region - this is illustrated in Figure 20 which depicts tapered openings for slots 116 in the apex of the bend in stem 114.
Figure 21 illustrates an alternate embodiment of the embodiment illustrated in Figures 15-20. Specifically, in Figure 21, second stent section 55, otherwise the same as that described hereinabove with reference to Figures 1-4, is adapted to include a landing 119 for receiving a solid (i.e. non-slot or non- porous) connection tab 120. Landing 119 may be connected to connection tab 120 as described hereinabove.
With reference to Figure 22, there is illustrated a variant to the embodiment illustrated in Figure 21. Specifically, in Figure 22, a connection tab 121 having the entire surface thereof slotted and otherwise porous is connected to landing 119.
While this invention has been described with reference to illustrative embodiments, this description is not intended to be construed in a limiting sense. Various modifications of the illustrative embodiments, as well as other embodiments of the invention, will be apparent to persons skilled in the art upon reference to this description. For example, while first connection tab 111 and second connection tab 112 have been illustrated as being attached to first stent portion 108, it is possible to have these tabs integral with second stent portion 55. Alternatively, the connection tabs do not have to integral with either of the stent portions and, instead, can be custom-designed, independent connection tabs which are affixed to both stent portions. Still further, it is possible for the connection tabs (integral or independent) to have a different thickness than either of the stent sections. It is therefore contemplated that the appended claims will cover any such modifications or embodiments.

Claims

What is claimed is:
1. An expandable bifurcated stent comprising a proximal end and a distal end in communication with one another, the proximal end comprising a primary passageway and the distal end comprising a pair of secondary passageways, each secondary passageway in communication with the primary passageway at a first intersection, the stent being expandable from a first, contracted position to a second, expanded position upon the application of a radially outward force exerted on the stent, each of the primary passageway and the secondary passageways being constructed of a tubular wall having a porous surface, at least one connection portion being disposed at the first intersection for reinforcing the first intersection.
2. The bifurcated stent defined in claim 1 , wherein the stent comprises a first stent section connected to a second stent section.
3. The bifurcated stent defined in claim 2, wherein an end of the first stent section is connected to an opening disposed along a length of the second stent section.
4. The bifurcated stent defined in claim 3, wherein a first connection portion is disposed at an end of the first stent section and is connect to the second stent section.
5. The bifurcated stent defined in claim 4, wherein the first connection portion is integral with an end of the first stent section.
6. The bifurcated stent defined in claim 4, wherein the first connection portion comprises a porous section and a non-porous section, the non-porous section connected to the second stent section.
7. The bifurcated stent defined in claim 6, wherein the porous section comprises a plurality of elongate slots.
8. The bifurcated stent defined in claim 7, wherein the elongate slots traverse the thickness of the at least one connection tab.
9. The bifurcated stent defined in claim 7, wherein the elongate slots are disposed substantially orthogonal to a longitudinal axis of the first stent section.
10. The bifurcated stent defined in claim 1, wherein the second stent section comprises a second connection portion along at least a portion of the periphery of the opening, the second connection portion connected to the first stent section.
11. The bifurcated stent defined in claim 2, wherein the first stent section and the second stent section are coaxially disposed with respect to one another along at least a portion of the primary passageway.
12. The bifurcated stent defined in claim 2, wherein the first stent section and the second stent section are coaxially disposed with respect to one another along substantially the entire length of the primary passageway.
13. The bifurcated stent defined in claim 2, wherein the first stent section and the second stent section are connected to one another and to a third stent section, at least one of the stent sections comprising the primary passageway and each of the other to stent sections comprising a secondary passageway.
14. The bifurcated stent defined in claim 1, wherein the at least one connection portion interconnects the pair of secondary passageways.
15. The bifurcated stent defined in claim 1 , wherein the at least one connection portion connects one of the pair of second passageways to the primary passageway.
16. A method for production of a bifurcated stent comprising the step of connecting a first stent section to a second stent section, the first stent section having an end thereof adapted for connection to an opening disposed along the length of a second stent section.
17. The method defined in claim 16 , wherein the end of the first stent section adapted for connection is bevelled with respect to a longitudinal axis of the first stent section.
18. The method defined in claim 16, comprising the further step of disposing at least one first flap portion at the end of the first stent section adapted for connection to a portion the second stent section.
19. The method defined in claim 18, wherein the at least one flap portion comprises a connection tab having a non-porous surface disposed on at least a portion thereof.
20. The method defined in claim 18, wherein the at least one flap portion comprises a connection tab having a porous surface disposed on at least a portion thereof.
21. The method defined in claim 20, wherein the porous surface comprises a plurality of substantially elongate slots.
22. The method defined in claim 18, wherein the at least one flap portion comprises a connection tab having both a porous surface and non-porous surface disposed thereon.
23. The method defined in claim 22, wherein the porous surface comprises a plurality of substantially elongate slots.
24. The method defined in claim 18, wherein the at least one first flap portion is produced by folding from the end of the first stent section adjacent the bevelled cut.
25. The method defined in claim 18, wherein, prior to the connecting step, the at least one first flap portion is trimmed to a reduced size.
26. The method defined in claim 18, comprising the further step of overlapping the at least one first flap portion of the first stent section on to a portion of the second stent section.
27. The method defined in claim 26, wherein the connecting step comprises welding the at least one first flap portion of the first stent section to the second stent section.
28. The method defined in claim 18, wherein, prior to the connecting step, the at least one first flap portion is removed.
29. The method defined in claim 16, comprising the further step of disposing at least one second flap portion at a periphery of the opening disposed along the length of the second stent section.
30. The method defined in claim 16, comprising the further step of disposing a pair of second flap portions at a periphery of the opening disposed along the length of the second stent section.
31. The method defined in claim 30, wherein, prior to the connecting step, at least one second flap portion is trimmed to a reduced size.
32. The method defined in claim 30, comprising the further step of overlapping the at least one second flap portion of the second stent section on to a portion of the first stent section.
33. The method defined in any one of claims 32, wherein the connecting step comprises welding the at least one second flap portion of the second stent section to the first stent section.
34. The method defined in claim 30, wherein, prior to the connecting step, at least one second flap portion is removed.
35. The method defined in claim 16, comprising the further steps of producing the second stent section by: providing a pair of third stent sections, each third stent sections having an end thereof bevelled with respect to a longitudinal axis of the third stent section; joining the pair of third stent sections in a complementary manner at each bevelled end thereof to provide a substantially V-shaped stent section; and removing an apex portion of the V-shaped stent section to define the second stent section having an opening therein.
36. The method defined in claim 35, wherein the connecting step comprises connecting the end of the first stent section to the opening defined in the V- shaped stent section.
37. The method defined in claim 16, wherein the connecting step comprises welding the first stent section to the second stent section.
38. A method for production of a bifurcated stent comprising the steps of: passing a first stent section having a first opening disposed along a length thereof through a second stent section having a second opening disposed along a length thereof, the first stent section having a diameter less than a diameter of the second stent section; passing a leading end of the first stent section through the second opening of the second stent section; and substantially aligning the first opening and the second opening with respect to one another.
39. An expandable bifurcated stent comprising a proximal end and a distal end in communication with one another, the proximal end comprising a primary passageway and the distal end comprising a pair of secondary passageways, each secondary passageway in communication with the primary passageway at a first intersection, the stent being expandable from a first, contracted position to a second, expanded position upon the application of a radially outward force exerted on the stent, each of the primary passageway and the secondary passageways having a porous surface, at least one connection portion interconnecting the pair of secondary passageways for reinforcing the first intersection.
PCT/CA1997/000294 1996-05-03 1997-05-02 Bifurcated stent and method for the manufacture of same WO1997041803A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP53936697A JP4659159B2 (en) 1996-05-03 1997-05-02 Bifurcated stent and manufacturing method thereof
AU23773/97A AU2377397A (en) 1996-05-03 1997-05-02 Bifurcated stent and method for the manufacture of same
EP97919222A EP0959811B1 (en) 1996-05-03 1997-05-02 Bifurcated stent and method for the manufacture of same
AT97919222T ATE270860T1 (en) 1996-05-03 1997-05-02 STENT WITH BRANCH AND PROCESS OF PRODUCTION THEREOF
CA2253546A CA2253546C (en) 1996-05-03 1997-05-02 Bifurcated stent and method for the manufacture of same
DE69729886T DE69729886T2 (en) 1996-05-03 1997-05-02 STENT WITH DISTRIBUTION AND ITS MANUFACTURING PROCESS
US09/180,146 US6811566B1 (en) 1996-05-03 1997-05-02 Bifurcated stent and method for the manufacture of same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2175720A CA2175720C (en) 1996-05-03 1996-05-03 Bifurcated stent and method for the manufacture and delivery of same
CA2,175,720 1996-05-03

Publications (1)

Publication Number Publication Date
WO1997041803A1 true WO1997041803A1 (en) 1997-11-13

Family

ID=4158131

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA1997/000294 WO1997041803A1 (en) 1996-05-03 1997-05-02 Bifurcated stent and method for the manufacture of same

Country Status (10)

Country Link
US (2) US5906640A (en)
EP (1) EP0959811B1 (en)
JP (1) JP4659159B2 (en)
AT (1) ATE270860T1 (en)
AU (1) AU2377397A (en)
CA (2) CA2175720C (en)
DE (1) DE69729886T2 (en)
ID (1) ID16864A (en)
MY (1) MY124237A (en)
WO (1) WO1997041803A1 (en)

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0897700A1 (en) * 1997-08-13 1999-02-24 Advanced Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcations
WO1999015103A1 (en) * 1997-09-23 1999-04-01 Carlos Vonderwalde Freidberg Bifurcated stent with flexible side portion
WO1999055253A1 (en) 1998-04-27 1999-11-04 Microval (S.A.R.L.) Tubular and flexible vascular prosthesis
WO2000007522A1 (en) 1998-07-31 2000-02-17 Novo Rps Ulc Small vessel expandable stent and method for production of same
US6071308A (en) * 1997-10-01 2000-06-06 Boston Scientific Corporation Flexible metal wire stent
US6096073A (en) * 1997-02-25 2000-08-01 Scimed Life Systems, Inc. Method of deploying a stent at a lesion site located at a bifurcation in a parent vessel
US6099497A (en) * 1998-03-05 2000-08-08 Scimed Life Systems, Inc. Dilatation and stent delivery system for bifurcation lesions
AU723672B2 (en) * 1998-02-24 2000-08-31 Cordis Corporation Bifurcated axially flexible stent
EP1047356A1 (en) * 1998-01-14 2000-11-02 Advanced Stent Technologies, Inc. Extendible stent apparatus
US6143002A (en) * 1998-08-04 2000-11-07 Scimed Life Systems, Inc. System for delivering stents to bifurcation lesions
EP1031329A3 (en) * 1999-02-24 2002-08-21 Cordis Corporation Bifurcated axially flexible stent
US6514281B1 (en) 1998-09-04 2003-02-04 Scimed Life Systems, Inc. System for delivering bifurcation stents
US6579309B1 (en) 1999-08-06 2003-06-17 Biotronik Mess-Und Therapiegerate Gmbh & Co. Ingenieurburo Berlin Stent for vessel branchings
US6835203B1 (en) * 1996-11-04 2004-12-28 Advanced Stent Technologies, Inc. Extendible stent apparatus
US7465315B2 (en) 2003-11-19 2008-12-16 Advanced Cardiovascular Systems, Inc. Portal design for stent for treating bifurcated vessels
US7662409B2 (en) 1998-09-25 2010-02-16 Gel-Del Technologies, Inc. Protein matrix materials, devices and methods of making and using thereof
US7842077B2 (en) 1997-09-22 2010-11-30 Cordis Corporation Bifurcated axially flexible stent
US8048142B2 (en) 2002-12-19 2011-11-01 Invatec S.R.L. Endolumenal prosthesis
US8444700B2 (en) 2007-02-12 2013-05-21 Bioregeneration Gmbh Medical implant and process for the production thereof
US8529939B2 (en) 2003-12-08 2013-09-10 Gel-Del Technologies, Inc. Mucoadhesive drug delivery devices and methods of making and using thereof
CN103826577A (en) * 2011-08-19 2014-05-28 哈利德·艾尔-萨阿敦 Stent system, deployment apparatus and method for bifurcated lesion
US8834554B2 (en) 2006-08-22 2014-09-16 Abbott Cardiovascular Systems Inc. Intravascular stent
US8882822B2 (en) 1997-09-23 2014-11-11 Design & Performance-Cyprus Limited Non-thrombogenic stent jacket
US8882826B2 (en) 2006-08-22 2014-11-11 Abbott Cardiovascular Systems Inc. Intravascular stent
US8932340B2 (en) 2008-05-29 2015-01-13 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
US8936567B2 (en) 2007-11-14 2015-01-20 Boston Scientific Scimed, Inc. Balloon bifurcated lumen treatment
US9107937B2 (en) 2003-08-26 2015-08-18 Gel-Del Technologies, Inc. Wound treatments with crosslinked protein amorphous biomaterials
US9149355B2 (en) 2004-09-21 2015-10-06 Cook Medical Technologies Llc Side branch stent graft
US9427340B2 (en) 2004-12-14 2016-08-30 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US9492297B2 (en) 2006-09-12 2016-11-15 Boston Scientific Scimed, Inc. Multilayer balloon for bifurcated stent delivery and methods of making and using the same
US9561126B2 (en) 1996-11-04 2017-02-07 Boston Scientific Scimed, Inc. Catheter with attached flexible side sheath
US10016534B2 (en) 2008-11-17 2018-07-10 Gel-Del Technologies, Inc. Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof
US11890371B2 (en) 2007-12-26 2024-02-06 Petvivo Holdings, Inc. Biocompatible protein-based particles and methods thereof

Families Citing this family (231)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6039749A (en) 1994-02-10 2000-03-21 Endovascular Systems, Inc. Method and apparatus for deploying non-circular stents and graftstent complexes
CA2134997C (en) * 1994-11-03 2009-06-02 Ian M. Penn Stent
US6991614B2 (en) 1995-11-07 2006-01-31 Boston Scientific Scimed, Inc. Ureteral stent for improved patient comfort
EP1477133B9 (en) 1996-03-05 2007-11-21 Evysio Medical Devices Ulc Expandable stent
CA2192520A1 (en) 1996-03-05 1997-09-05 Ian M. Penn Expandable stent and method for delivery of same
US6796997B1 (en) 1996-03-05 2004-09-28 Evysio Medical Devices Ulc Expandable stent
US6440165B1 (en) * 1996-05-03 2002-08-27 Medinol, Ltd. Bifurcated stent with improved side branch aperture and method of making same
US6770092B2 (en) 1996-05-03 2004-08-03 Medinol Ltd. Method of delivering a bifurcated stent
US7641685B2 (en) * 1996-05-03 2010-01-05 Medinol Ltd. System and method for delivering a bifurcated stent
US6251133B1 (en) * 1996-05-03 2001-06-26 Medinol Ltd. Bifurcated stent with improved side branch aperture and method of making same
UA58485C2 (en) 1996-05-03 2003-08-15 Медінол Лтд. Method for manufacture of bifurcated stent (variants) and bifurcated stent (variants)
US6007573A (en) * 1996-09-18 1999-12-28 Microtherapeutics, Inc. Intracranial stent and method of use
US5989276A (en) * 1996-11-08 1999-11-23 Advanced Bypass Technologies, Inc. Percutaneous bypass graft and securing system
US6599316B2 (en) 1996-11-04 2003-07-29 Advanced Stent Technologies, Inc. Extendible stent apparatus
US7341598B2 (en) * 1999-01-13 2008-03-11 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
AU4896797A (en) * 1996-11-04 1998-05-29 Davidson, Charles Extendible stent apparatus and method for deploying the same
US6682536B2 (en) 2000-03-22 2004-01-27 Advanced Stent Technologies, Inc. Guidewire introducer sheath
US7591846B2 (en) 1996-11-04 2009-09-22 Boston Scientific Scimed, Inc. Methods for deploying stents in bifurcations
US6325826B1 (en) 1998-01-14 2001-12-04 Advanced Stent Technologies, Inc. Extendible stent apparatus
US6692483B2 (en) 1996-11-04 2004-02-17 Advanced Stent Technologies, Inc. Catheter with attached flexible side sheath
US7959664B2 (en) * 1996-12-26 2011-06-14 Medinol, Ltd. Flat process of drug coating for stents
US5906759A (en) * 1996-12-26 1999-05-25 Medinol Ltd. Stent forming apparatus with stent deforming blades
GB9703859D0 (en) * 1997-02-25 1997-04-16 Plante Sylvain Expandable intravascular stent
FR2760351B1 (en) * 1997-03-04 1999-05-28 Bernard Glatt HELICAL STENT FORMING DEVICE AND MANUFACTURING METHOD THEREOF
US6409755B1 (en) * 1997-05-29 2002-06-25 Scimed Life Systems, Inc. Balloon expandable stent with a self-expanding portion
US6070589A (en) 1997-08-01 2000-06-06 Teramed, Inc. Methods for deploying bypass graft stents
US6261241B1 (en) * 1998-03-03 2001-07-17 Senorx, Inc. Electrosurgical biopsy device and method
US6290731B1 (en) 1998-03-30 2001-09-18 Cordis Corporation Aortic graft having a precursor gasket for repairing an abdominal aortic aneurysm
US6656215B1 (en) 2000-11-16 2003-12-02 Cordis Corporation Stent graft having an improved means for attaching a stent to a graft
US6261273B1 (en) * 1998-05-07 2001-07-17 Carlos E. Ruiz Access system for branched vessels amd methods of use
US6168621B1 (en) * 1998-05-29 2001-01-02 Scimed Life Systems, Inc. Balloon expandable stent with a self-expanding portion
US6740113B2 (en) * 1998-05-29 2004-05-25 Scimed Life Systems, Inc. Balloon expandable stent with a self-expanding portion
US6066169A (en) * 1998-06-02 2000-05-23 Ave Connaught Expandable stent having articulated connecting rods
WO1999065419A1 (en) * 1998-06-19 1999-12-23 Endologix, Inc. Self expanding bifurcated endovascular prosthesis
US6193744B1 (en) * 1998-09-10 2001-02-27 Scimed Life Systems, Inc. Stent configurations
US6187036B1 (en) 1998-12-11 2001-02-13 Endologix, Inc. Endoluminal vascular prosthesis
DE69927055T2 (en) * 1998-12-11 2006-06-29 Endologix, Inc., Irvine ENDOLUMINAL VASCULAR PROSTHESIS
US6197049B1 (en) 1999-02-17 2001-03-06 Endologix, Inc. Articulating bifurcation graft
US6660030B2 (en) 1998-12-11 2003-12-09 Endologix, Inc. Bifurcation graft deployment catheter
US6733523B2 (en) 1998-12-11 2004-05-11 Endologix, Inc. Implantable vascular graft
US6059824A (en) * 1998-12-23 2000-05-09 Taheri; Syde A. Mated main and collateral stent and method for treatment of arterial disease
US7655030B2 (en) 2003-07-18 2010-02-02 Boston Scientific Scimed, Inc. Catheter balloon systems and methods
US8257425B2 (en) 1999-01-13 2012-09-04 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US6332892B1 (en) 1999-03-02 2001-12-25 Scimed Life Systems, Inc. Medical device with one or more helical coils
US8034100B2 (en) 1999-03-11 2011-10-11 Endologix, Inc. Graft deployment system
US6261316B1 (en) 1999-03-11 2001-07-17 Endologix, Inc. Single puncture bifurcation graft deployment system
WO2000057813A1 (en) * 1999-03-30 2000-10-05 Angiolink Corporation Angular vascular stent
US6273911B1 (en) 1999-04-22 2001-08-14 Advanced Cardiovascular Systems, Inc. Variable strength stent
US6402779B1 (en) 1999-07-26 2002-06-11 Endomed, Inc. Balloon-assisted intraluminal stent graft
US6183481B1 (en) 1999-09-22 2001-02-06 Endomed Inc. Delivery system for self-expanding stents and grafts
US6689156B1 (en) 1999-09-23 2004-02-10 Advanced Stent Technologies, Inc. Stent range transducers and methods of use
US7226475B2 (en) * 1999-11-09 2007-06-05 Boston Scientific Scimed, Inc. Stent with variable properties
US6679910B1 (en) 1999-11-12 2004-01-20 Latin American Devices Llc Intraluminal stent
DE60123807T2 (en) 2000-08-23 2007-10-11 Lemaitre Acquisition Llc METHOD FOR PRODUCING INTRAVASCULAR DEVICES TO MEASURE
US6908477B2 (en) * 2000-10-13 2005-06-21 Rex Medical, L.P. Methods of implanting covered stents with side branch
US7267685B2 (en) * 2000-11-16 2007-09-11 Cordis Corporation Bilateral extension prosthesis and method of delivery
US8870946B1 (en) * 2000-12-11 2014-10-28 W.L. Gore & Associates, Inc. Method of deploying a bifurcated side-access intravascular stent graft
US20010044650A1 (en) * 2001-01-12 2001-11-22 Simso Eric J. Stent for in-stent restenosis
AU2002250189A1 (en) 2001-02-26 2002-09-12 Scimed Life Systems, Inc. Bifurcated stent and delivery system
US7799064B2 (en) * 2001-02-26 2010-09-21 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
WO2002067815A1 (en) 2001-02-26 2002-09-06 Scimed Life Systems, Inc. Bifurcated stent
US6719804B2 (en) 2001-04-02 2004-04-13 Scimed Life Systems, Inc. Medical stent and related methods
US7232460B2 (en) * 2001-04-25 2007-06-19 Xillus, Inc. Nanodevices, microdevices and sensors on in-vivo structures and method for the same
US8617231B2 (en) 2001-05-18 2013-12-31 Boston Scientific Scimed, Inc. Dual guidewire exchange catheter system
ES2319621T3 (en) * 2001-08-23 2009-05-11 Darrell C. Gumm ROTARY SYSTEM OF IMPLANT OF ENDOVASCULAR PROTESIS FOR ACCSO OF SIDE BRANCH AND PROTECTION.
US6620202B2 (en) 2001-10-16 2003-09-16 Scimed Life Systems, Inc. Medical stent with variable coil and related methods
US7029496B2 (en) * 2001-11-07 2006-04-18 Scimed Life Systems, Inc. Interlocking endoluminal device
US7014653B2 (en) * 2001-12-20 2006-03-21 Cleveland Clinic Foundation Furcated endovascular prosthesis
US7147661B2 (en) 2001-12-20 2006-12-12 Boston Scientific Santa Rosa Corp. Radially expandable stent
US6682537B2 (en) 2001-12-20 2004-01-27 The Cleveland Clinic Foundation Apparatus and method for capturing a wire in a blood vessel
US6641606B2 (en) 2001-12-20 2003-11-04 Cleveland Clinic Foundation Delivery system and method for deploying an endovascular prosthesis
US7029493B2 (en) * 2002-01-25 2006-04-18 Cordis Corporation Stent with enhanced crossability
US6989024B2 (en) 2002-02-28 2006-01-24 Counter Clockwise, Inc. Guidewire loaded stent for delivery through a catheter
US8328877B2 (en) 2002-03-19 2012-12-11 Boston Scientific Scimed, Inc. Stent retention element and related methods
EP1405613B1 (en) * 2002-10-04 2006-03-22 Sorin Biomedica Cardio S.R.L. An implant device for treating aneurisms of the abdominal aorta
US7326242B2 (en) * 2002-11-05 2008-02-05 Boston Scientific Scimed, Inc. Asymmetric bifurcated crown
US7300460B2 (en) * 2002-12-31 2007-11-27 Counter Clockwise, Inc. Bifurcated guidewire and methods of use
US7169177B2 (en) * 2003-01-15 2007-01-30 Boston Scientific Scimed, Inc. Bifurcated stent
US7367989B2 (en) * 2003-02-27 2008-05-06 Scimed Life Systems, Inc. Rotating balloon expandable sheath bifurcation delivery
US7314480B2 (en) * 2003-02-27 2008-01-01 Boston Scientific Scimed, Inc. Rotating balloon expandable sheath bifurcation delivery
US8109987B2 (en) 2003-04-14 2012-02-07 Tryton Medical, Inc. Method of treating a lumenal bifurcation
US7731747B2 (en) * 2003-04-14 2010-06-08 Tryton Medical, Inc. Vascular bifurcation prosthesis with multiple thin fronds
US7717953B2 (en) * 2004-10-13 2010-05-18 Tryton Medical, Inc. Delivery system for placement of prosthesis at luminal OS
US7972372B2 (en) * 2003-04-14 2011-07-05 Tryton Medical, Inc. Kit for treating vascular bifurcations
US7481834B2 (en) * 2003-04-14 2009-01-27 Tryton Medical, Inc. Stent for placement at luminal os
US8083791B2 (en) 2003-04-14 2011-12-27 Tryton Medical, Inc. Method of treating a lumenal bifurcation
US7758630B2 (en) 2003-04-14 2010-07-20 Tryton Medical, Inc. Helical ostium support for treating vascular bifurcations
US20040215220A1 (en) * 2003-04-24 2004-10-28 Dolan Mark J. Anastomotic stent, apparatus and methods of use thereof
US20070032852A1 (en) * 2003-04-25 2007-02-08 Medtronic Vascular, Inc. Methods and Apparatus for Treatment of Aneurysms Adjacent to Branch Arteries
US7438721B2 (en) * 2003-04-25 2008-10-21 Medtronic Vascular, Inc. Universal modular stent graft assembly to accommodate flow to collateral branches
US7105015B2 (en) * 2003-06-17 2006-09-12 Medtronic Vascular, Inc. Method and system for treating an ostium of a side-branch vessel
US20050033406A1 (en) * 2003-07-15 2005-02-10 Barnhart William H. Branch vessel stent and graft
US8784472B2 (en) * 2003-08-15 2014-07-22 Boston Scientific Scimed, Inc. Clutch driven stent delivery system
US7628806B2 (en) * 2003-08-20 2009-12-08 Boston Scientific Scimed, Inc. Stent with improved resistance to migration
US8298280B2 (en) 2003-08-21 2012-10-30 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US7413573B2 (en) 2003-10-10 2008-08-19 William A. Cook Australia Pty. Ltd. Fenestrated stent grafts
US9278015B2 (en) * 2003-10-16 2016-03-08 Minvasys Catheter system for stenting and drug treatment of bifurcated vessels
US7641684B2 (en) * 2003-10-16 2010-01-05 Minvasys, Sa Catheter system for stenting bifurcated vessels
US7344557B2 (en) 2003-11-12 2008-03-18 Advanced Stent Technologies, Inc. Catheter balloon systems and methods
US7686841B2 (en) * 2003-12-29 2010-03-30 Boston Scientific Scimed, Inc. Rotating balloon expandable sheath bifurcation delivery system
US7922753B2 (en) 2004-01-13 2011-04-12 Boston Scientific Scimed, Inc. Bifurcated stent delivery system
US8012192B2 (en) * 2004-02-18 2011-09-06 Boston Scientific Scimed, Inc. Multi-stent delivery system
US7225518B2 (en) * 2004-02-23 2007-06-05 Boston Scientific Scimed, Inc. Apparatus for crimping a stent assembly
US7922740B2 (en) 2004-02-24 2011-04-12 Boston Scientific Scimed, Inc. Rotatable catheter assembly
US7744619B2 (en) * 2004-02-24 2010-06-29 Boston Scientific Scimed, Inc. Rotatable catheter assembly
US8007528B2 (en) 2004-03-17 2011-08-30 Boston Scientific Scimed, Inc. Bifurcated stent
EP1789126A4 (en) * 2004-05-21 2008-03-12 Minvasys Sa Guidewire separator device and method of use
AU2010236494B2 (en) 2004-05-25 2013-05-30 Covidien Lp Vascular stenting for aneurysms
US8617234B2 (en) 2004-05-25 2013-12-31 Covidien Lp Flexible vascular occluding device
US8628564B2 (en) 2004-05-25 2014-01-14 Covidien Lp Methods and apparatus for luminal stenting
US8267985B2 (en) * 2005-05-25 2012-09-18 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
EP1750619B1 (en) 2004-05-25 2013-07-24 Covidien LP Flexible vascular occluding device
US20060206200A1 (en) 2004-05-25 2006-09-14 Chestnut Medical Technologies, Inc. Flexible vascular occluding device
US20050273149A1 (en) * 2004-06-08 2005-12-08 Tran Thomas T Bifurcated stent delivery system
JP5054524B2 (en) 2004-06-08 2012-10-24 アドバンスド ステント テクノロジーズ, インコーポレイテッド Stent with protruding branch for branch pipe
US20060064064A1 (en) * 2004-09-17 2006-03-23 Jang G D Two-step/dual-diameter balloon angioplasty catheter for bifurcation and side-branch vascular anatomy
US7196014B2 (en) * 2004-11-08 2007-03-27 International Business Machines Corporation System and method for plasma induced modification and improvement of critical dimension uniformity
WO2006065644A1 (en) * 2004-12-17 2006-06-22 William A. Cook Australia Pty. Ltd. Stented side branch graft
US20080188803A1 (en) * 2005-02-03 2008-08-07 Jang G David Triple-profile balloon catheter
US7828837B2 (en) * 2005-02-17 2010-11-09 Khoury Medical Devices, LLC. Vascular endograft
US9597209B2 (en) * 2005-02-17 2017-03-21 Khoury Medical Devices, Llc Vascular endograft
US7947207B2 (en) 2005-04-12 2011-05-24 Abbott Cardiovascular Systems Inc. Method for retaining a vascular stent on a catheter
US7763198B2 (en) 2005-04-12 2010-07-27 Abbott Cardiovascular Systems Inc. Method for retaining a vascular stent on a catheter
US8273101B2 (en) 2005-05-25 2012-09-25 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
EP1883371B1 (en) 2005-05-25 2015-10-07 Covidien LP System and method for delivering and deploying and occluding device within a vessel
US8317855B2 (en) 2005-05-26 2012-11-27 Boston Scientific Scimed, Inc. Crimpable and expandable side branch cell
US8480728B2 (en) 2005-05-26 2013-07-09 Boston Scientific Scimed, Inc. Stent side branch deployment initiation geometry
CA2610703C (en) * 2005-06-01 2014-07-22 William A. Cook Australia Pty. Ltd. Side branch stent graft
US20070050016A1 (en) * 2005-08-29 2007-03-01 Boston Scientific Scimed, Inc. Stent with expanding side branch geometry
US7955374B2 (en) * 2005-09-02 2011-06-07 Medtronic Vascular, Inc. Modular branch vessel stent-graft assembly
US8038706B2 (en) 2005-09-08 2011-10-18 Boston Scientific Scimed, Inc. Crown stent assembly
US8043366B2 (en) 2005-09-08 2011-10-25 Boston Scientific Scimed, Inc. Overlapping stent
US7731741B2 (en) * 2005-09-08 2010-06-08 Boston Scientific Scimed, Inc. Inflatable bifurcation stent
US20070106375A1 (en) * 2005-11-07 2007-05-10 Carlos Vonderwalde Bifurcated stent assembly
US20070112418A1 (en) * 2005-11-14 2007-05-17 Boston Scientific Scimed, Inc. Stent with spiral side-branch support designs
US20070123970A1 (en) * 2005-11-29 2007-05-31 Boston Scientific Scimed, Inc. Bifurcation stent with overlapping crimped struts
US8343211B2 (en) 2005-12-14 2013-01-01 Boston Scientific Scimed, Inc. Connectors for bifurcated stent
US8435284B2 (en) 2005-12-14 2013-05-07 Boston Scientific Scimed, Inc. Telescoping bifurcated stent
US20070142904A1 (en) * 2005-12-20 2007-06-21 Boston Scientific Scimed, Inc. Bifurcated stent with multiple locations for side branch access
US7540881B2 (en) 2005-12-22 2009-06-02 Boston Scientific Scimed, Inc. Bifurcation stent pattern
WO2007095031A2 (en) * 2006-02-13 2007-08-23 Bay Street Medical, Inc. System for delivering a stent
US8821561B2 (en) 2006-02-22 2014-09-02 Boston Scientific Scimed, Inc. Marker arrangement for bifurcation catheter
US8152833B2 (en) 2006-02-22 2012-04-10 Tyco Healthcare Group Lp Embolic protection systems having radiopaque filter mesh
US20070208419A1 (en) * 2006-03-06 2007-09-06 Boston Scientific Scimed, Inc. Bifurcation stent with uniform side branch projection
US20070208411A1 (en) * 2006-03-06 2007-09-06 Boston Scientific Scimed, Inc. Bifurcated stent with surface area gradient
US20070208414A1 (en) * 2006-03-06 2007-09-06 Shawn Sorenson Tapered strength rings on a bifurcated stent petal
US20070208415A1 (en) * 2006-03-06 2007-09-06 Kevin Grotheim Bifurcated stent with controlled drug delivery
US7833264B2 (en) 2006-03-06 2010-11-16 Boston Scientific Scimed, Inc. Bifurcated stent
US8298278B2 (en) * 2006-03-07 2012-10-30 Boston Scientific Scimed, Inc. Bifurcated stent with improvement securement
US20070270933A1 (en) * 2006-03-09 2007-11-22 Abbott Laboratories Stent having contoured proximal end
US8167929B2 (en) 2006-03-09 2012-05-01 Abbott Laboratories System and method for delivering a stent to a bifurcated vessel
US8828077B2 (en) 2006-03-15 2014-09-09 Medinol Ltd. Flat process of preparing drug eluting stents
US20070225798A1 (en) * 2006-03-23 2007-09-27 Daniel Gregorich Side branch stent
US8043358B2 (en) * 2006-03-29 2011-10-25 Boston Scientific Scimed, Inc. Stent with overlap and high extension
US8348991B2 (en) * 2006-03-29 2013-01-08 Boston Scientific Scimed, Inc. Stent with overlap and high expansion
US20070239261A1 (en) * 2006-04-07 2007-10-11 Arani Bose Aneurysm occlusion system and method
US20070260304A1 (en) * 2006-05-02 2007-11-08 Daniel Gregorich Bifurcated stent with minimally circumferentially projected side branch
EP2051673A2 (en) 2006-06-23 2009-04-29 Boston Scientific Limited Bifurcated stent with twisted hinges
US7951191B2 (en) 2006-10-10 2011-05-31 Boston Scientific Scimed, Inc. Bifurcated stent with entire circumferential petal
US20080097578A1 (en) * 2006-10-20 2008-04-24 Medtronic Vascular, Inc. Extender Cuff for Branch Vessel
US8206429B2 (en) 2006-11-02 2012-06-26 Boston Scientific Scimed, Inc. Adjustable bifurcation catheter incorporating electroactive polymer and methods of making and using the same
US7842082B2 (en) 2006-11-16 2010-11-30 Boston Scientific Scimed, Inc. Bifurcated stent
US8523931B2 (en) 2007-01-12 2013-09-03 Endologix, Inc. Dual concentric guidewire and methods of bifurcated graft deployment
US7959668B2 (en) 2007-01-16 2011-06-14 Boston Scientific Scimed, Inc. Bifurcated stent
US20080177367A1 (en) * 2007-01-22 2008-07-24 Adam Stys Treatment device for treating a side branch of a vessel and method for positioning a stent in a side branch
US20080177370A1 (en) * 2007-01-22 2008-07-24 Adam Stys Device and method for supporting a side branch of a vessel
US20080255654A1 (en) * 2007-03-22 2008-10-16 Bay Street Medical System for delivering a stent
US8118861B2 (en) 2007-03-28 2012-02-21 Boston Scientific Scimed, Inc. Bifurcation stent and balloon assemblies
US8647376B2 (en) 2007-03-30 2014-02-11 Boston Scientific Scimed, Inc. Balloon fold design for deployment of bifurcated stent petal architecture
US9144508B2 (en) * 2007-07-19 2015-09-29 Back Bay Medical Inc. Radially expandable stent
US8486134B2 (en) 2007-08-01 2013-07-16 Boston Scientific Scimed, Inc. Bifurcation treatment system and methods
US7959669B2 (en) 2007-09-12 2011-06-14 Boston Scientific Scimed, Inc. Bifurcated stent with open ended side branch support
US7833266B2 (en) 2007-11-28 2010-11-16 Boston Scientific Scimed, Inc. Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment
US8277501B2 (en) * 2007-12-21 2012-10-02 Boston Scientific Scimed, Inc. Bi-stable bifurcated stent petal geometry
EP2242456A2 (en) 2007-12-31 2010-10-27 Boston Scientific Scimed, Inc. Bifurcation stent delivery system and methods
EP3964243A1 (en) * 2008-01-28 2022-03-09 Implantica Patent Ltd Blood clot removal device, system, and method
WO2009105699A1 (en) 2008-02-22 2009-08-27 Endologix, Inc. Design and method of placement of a graft or graft system
US20090240318A1 (en) * 2008-03-19 2009-09-24 Boston Scientific Scimed, Inc. Stent expansion column, strut and connector slit design
US8236040B2 (en) 2008-04-11 2012-08-07 Endologix, Inc. Bifurcated graft deployment systems and methods
US9675482B2 (en) 2008-05-13 2017-06-13 Covidien Lp Braid implant delivery systems
US8333003B2 (en) * 2008-05-19 2012-12-18 Boston Scientific Scimed, Inc. Bifurcation stent crimping systems and methods
US8377108B2 (en) 2008-06-02 2013-02-19 Boston Scientific Scimed, Inc. Staggered two balloon bifurcation catheter assembly and methods
JP5662310B2 (en) 2008-06-05 2015-01-28 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Shrinkable branch device and method of manufacturing the same
WO2010002931A1 (en) 2008-07-01 2010-01-07 Endologix, Inc. Catheter system
US8133199B2 (en) 2008-08-27 2012-03-13 Boston Scientific Scimed, Inc. Electroactive polymer activation system for a medical device
US8821562B2 (en) 2008-09-25 2014-09-02 Advanced Bifurcation Systems, Inc. Partially crimped stent
CA2739007C (en) 2008-09-25 2017-10-31 Advanced Bifurcation Systems Inc. Partially crimped stent
US8769796B2 (en) 2008-09-25 2014-07-08 Advanced Bifurcation Systems, Inc. Selective stent crimping
US11298252B2 (en) 2008-09-25 2022-04-12 Advanced Bifurcation Systems Inc. Stent alignment during treatment of a bifurcation
US8979917B2 (en) 2008-09-25 2015-03-17 Advanced Bifurcation Systems, Inc. System and methods for treating a bifurcation
NZ592905A (en) * 2008-10-27 2012-11-30 Baxter Int Models of thrombotic thrombocytopenic purpura and methods of use thereof
US20100121247A1 (en) * 2008-11-13 2010-05-13 Chen Yang Dialysis Graft with Thromboses Prevention Arrangement
US20110054586A1 (en) 2009-04-28 2011-03-03 Endologix, Inc. Apparatus and method of placement of a graft or graft system
US10772717B2 (en) 2009-05-01 2020-09-15 Endologix, Inc. Percutaneous method and device to treat dissections
EP2424447A2 (en) 2009-05-01 2012-03-07 Endologix, Inc. Percutaneous method and device to treat dissections
US8382818B2 (en) * 2009-07-02 2013-02-26 Tryton Medical, Inc. Ostium support for treating vascular bifurcations
WO2011008989A2 (en) 2009-07-15 2011-01-20 Endologix, Inc. Stent graft
JP5588511B2 (en) 2009-07-27 2014-09-10 エンドロジックス、インク Stent graft
AU2010201067B1 (en) * 2010-03-19 2011-06-09 Cook Incorporated Thoracic stent graft
WO2011119883A1 (en) 2010-03-24 2011-09-29 Advanced Bifurcation Systems, Inc. Stent alignment during treatment of a bifurcation
AU2011232360B2 (en) 2010-03-24 2015-10-08 Advanced Bifurcation Systems Inc. Methods and systems for treating a bifurcation with provisional side branch stenting
US9402754B2 (en) 2010-05-18 2016-08-02 Abbott Cardiovascular Systems, Inc. Expandable endoprostheses, systems, and methods for treating a bifurcated lumen
EP2635241B1 (en) 2010-11-02 2019-02-20 Endologix, Inc. Apparatus for placement of a graft or graft system
WO2012068298A1 (en) 2010-11-17 2012-05-24 Endologix, Inc. Devices and methods to treat vascular dissections
US9707108B2 (en) 2010-11-24 2017-07-18 Tryton Medical, Inc. Support for treating vascular bifurcations
EP2672932B1 (en) 2011-02-08 2018-09-19 Advanced Bifurcation Systems, Inc. System for treating a bifurcation with a fully crimped stent
EP2672925B1 (en) 2011-02-08 2017-05-03 Advanced Bifurcation Systems, Inc. Multi-stent and multi-balloon apparatus for treating bifurcations
US8808350B2 (en) 2011-03-01 2014-08-19 Endologix, Inc. Catheter system and methods of using same
WO2013162724A1 (en) 2012-04-26 2013-10-31 Tryton Medical, Inc. Support for treating vascular bifurcations
JP6220386B2 (en) 2012-05-14 2017-10-25 シー・アール・バード・インコーポレーテッドC R Bard Incorporated Uniformly expandable stent
US9155647B2 (en) 2012-07-18 2015-10-13 Covidien Lp Methods and apparatus for luminal stenting
JP6246209B2 (en) * 2012-08-20 2017-12-13 アル−サードン,カーリッド Bifurcated double balloon catheter system for bifurcated body vessels
KR101231197B1 (en) * 2012-09-20 2013-02-07 썬텍 주식회사 Polymeric stent
US9114001B2 (en) 2012-10-30 2015-08-25 Covidien Lp Systems for attaining a predetermined porosity of a vascular device
US9452070B2 (en) 2012-10-31 2016-09-27 Covidien Lp Methods and systems for increasing a density of a region of a vascular device
US9943427B2 (en) 2012-11-06 2018-04-17 Covidien Lp Shaped occluding devices and methods of using the same
US9157174B2 (en) 2013-02-05 2015-10-13 Covidien Lp Vascular device for aneurysm treatment and providing blood flow into a perforator vessel
USD723165S1 (en) 2013-03-12 2015-02-24 C. R. Bard, Inc. Stent
CN105050614B (en) 2013-03-15 2019-04-05 加利福尼亚大学董事会 Stimulate the peptide with reduced toxicity of Cholesterol Efflux
US10034784B2 (en) * 2013-04-17 2018-07-31 Gilbert H. L. Tang Heart valve and endovascular graft components and method for delivery
JP6128689B2 (en) * 2013-11-29 2017-05-17 弘志 岩村 Artificial blood vessel
US9468545B2 (en) 2014-04-04 2016-10-18 W. L. Gore & Associates, Inc. Bifurcated graft device
US20160000985A1 (en) * 2014-07-02 2016-01-07 Abbott Cardiovascular Systems Inc. Extravascular devices supporting an arteriovenous fistula
US10959826B2 (en) 2014-10-16 2021-03-30 Cook Medical Technology LLC Support structure for scalloped grafts
US10179057B2 (en) * 2015-05-28 2019-01-15 George Kramer Tracheobronchial Y-stents, delivery catheters and delivery apparatus, and methods for delivering bronchial Y-stents
US11129737B2 (en) 2015-06-30 2021-09-28 Endologix Llc Locking assembly for coupling guidewire to delivery system
US10130465B2 (en) * 2016-02-23 2018-11-20 Abbott Cardiovascular Systems Inc. Bifurcated tubular graft for treating tricuspid regurgitation
US10772719B2 (en) * 2017-02-14 2020-09-15 Cook Medical Technologies Llc Method of making a contoured internal limb for a prosthesis and prosthesis with a contoured internal limb
KR101968602B1 (en) * 2017-04-28 2019-04-15 주식회사 에스앤지바이오텍 Drainage catheter
CN113238471B (en) * 2021-05-20 2023-11-17 中国科学技术大学 Rapid preparation method of bifurcated micro-pipeline
DE102021132725A1 (en) * 2021-12-10 2023-06-15 Phenox Gmbh Implant for the treatment of aneurysms in the area of bifurcations

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2479578A (en) * 1943-09-25 1949-08-23 Babcock & Wilcox Co Tubular structure
US3993078A (en) * 1974-11-04 1976-11-23 Gambro Ag Insert for use preferably in vascular surgery
US4994071A (en) * 1989-05-22 1991-02-19 Cordis Corporation Bifurcating stent apparatus and method
US5342387A (en) * 1992-06-18 1994-08-30 American Biomed, Inc. Artificial support for a blood vessel
WO1996034580A1 (en) * 1995-05-04 1996-11-07 Alain Dibie Endoprosthesis for the treatment of blood-vessel bifurcation stenosis and purpose-built installation device

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155095A (en) * 1961-02-07 1964-11-03 Adolph M Brown Anastomosis method and means
CA1322628C (en) * 1988-10-04 1993-10-05 Richard A. Schatz Expandable intraluminal graft
US5360443A (en) * 1990-06-11 1994-11-01 Barone Hector D Aortic graft for repairing an abdominal aortic aneurysm
CA2087132A1 (en) * 1992-01-31 1993-08-01 Michael S. Williams Stent capable of attachment within a body lumen
US5639278A (en) * 1993-10-21 1997-06-17 Corvita Corporation Expandable supportive bifurcated endoluminal grafts
US5609627A (en) * 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US5609605A (en) * 1994-08-25 1997-03-11 Ethicon, Inc. Combination arterial stent
US5653743A (en) * 1994-09-09 1997-08-05 Martin; Eric C. Hypogastric artery bifurcation graft and method of implantation
JP2911763B2 (en) * 1994-10-27 1999-06-23 三桜子 布川 Artificial blood vessel
US5683449A (en) * 1995-02-24 1997-11-04 Marcade; Jean Paul Modular bifurcated intraluminal grafts and methods for delivering and assembling same
CA2171896C (en) * 1995-03-17 2007-05-15 Scott C. Anderson Multi-anchor stent
US5709713A (en) * 1995-03-31 1998-01-20 Cardiovascular Concepts, Inc. Radially expansible vascular prosthesis having reversible and other locking structures
US5669924A (en) * 1995-10-26 1997-09-23 Shaknovich; Alexander Y-shuttle stent assembly for bifurcating vessels and method of using the same
UA58485C2 (en) * 1996-05-03 2003-08-15 Медінол Лтд. Method for manufacture of bifurcated stent (variants) and bifurcated stent (variants)
US5676697A (en) * 1996-07-29 1997-10-14 Cardiovascular Dynamics, Inc. Two-piece, bifurcated intraluminal graft for repair of aneurysm
US5728150A (en) * 1996-07-29 1998-03-17 Cardiovascular Dynamics, Inc. Expandable microporous prosthesis
US6086611A (en) * 1997-09-25 2000-07-11 Ave Connaught Bifurcated stent
US5893887A (en) * 1997-10-14 1999-04-13 Iowa-India Investments Company Limited Stent for positioning at junction of bifurcated blood vessel and method of making

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2479578A (en) * 1943-09-25 1949-08-23 Babcock & Wilcox Co Tubular structure
US3993078A (en) * 1974-11-04 1976-11-23 Gambro Ag Insert for use preferably in vascular surgery
US4994071A (en) * 1989-05-22 1991-02-19 Cordis Corporation Bifurcating stent apparatus and method
US5342387A (en) * 1992-06-18 1994-08-30 American Biomed, Inc. Artificial support for a blood vessel
WO1996034580A1 (en) * 1995-05-04 1996-11-07 Alain Dibie Endoprosthesis for the treatment of blood-vessel bifurcation stenosis and purpose-built installation device

Cited By (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6835203B1 (en) * 1996-11-04 2004-12-28 Advanced Stent Technologies, Inc. Extendible stent apparatus
US7678142B2 (en) * 1996-11-04 2010-03-16 Boston Scientific Scimed, Inc. Extendible stent apparatus
US9561126B2 (en) 1996-11-04 2017-02-07 Boston Scientific Scimed, Inc. Catheter with attached flexible side sheath
US6096073A (en) * 1997-02-25 2000-08-01 Scimed Life Systems, Inc. Method of deploying a stent at a lesion site located at a bifurcation in a parent vessel
EP1199052A3 (en) * 1997-08-13 2003-03-12 Advanced Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcations
EP0897700A1 (en) * 1997-08-13 1999-02-24 Advanced Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcations
EP1199052A2 (en) 1997-08-13 2002-04-24 Advanced Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcations
US7842077B2 (en) 1997-09-22 2010-11-30 Cordis Corporation Bifurcated axially flexible stent
AU747698B2 (en) * 1997-09-23 2002-05-16 Design & Performance - Cyprus Limited Bifurcated stent with flexible side portion
WO1999015103A1 (en) * 1997-09-23 1999-04-01 Carlos Vonderwalde Freidberg Bifurcated stent with flexible side portion
US8882822B2 (en) 1997-09-23 2014-11-11 Design & Performance-Cyprus Limited Non-thrombogenic stent jacket
US6723118B1 (en) 1997-10-01 2004-04-20 Scimed Life Systems, Inc. Flexible metal wire stent
US6071308A (en) * 1997-10-01 2000-06-06 Boston Scientific Corporation Flexible metal wire stent
US6976994B2 (en) 1997-10-01 2005-12-20 Boston Scientific Scimed, Inc. Flexible metal wire stent
EP1047356A1 (en) * 1998-01-14 2000-11-02 Advanced Stent Technologies, Inc. Extendible stent apparatus
JP2003532437A (en) * 1998-01-14 2003-11-05 アドバンスト・ステント・テクノロジーズ・インコーポレーテッド Stretchable stent device
EP1047356A4 (en) * 1998-01-14 2004-06-16 Advanced Stent Tech Inc Extendible stent apparatus
AU723672B2 (en) * 1998-02-24 2000-08-31 Cordis Corporation Bifurcated axially flexible stent
US6099497A (en) * 1998-03-05 2000-08-08 Scimed Life Systems, Inc. Dilatation and stent delivery system for bifurcation lesions
US8088102B2 (en) 1998-03-05 2012-01-03 Boston Scientific Scimed, Inc. Dilation and stent delivery system for bifurcation lesions
US7445610B2 (en) 1998-03-05 2008-11-04 Boston Scientific Scimed, Inc. Dilation and stent delivery system for bifurcation lesions
WO1999055253A1 (en) 1998-04-27 1999-11-04 Microval (S.A.R.L.) Tubular and flexible vascular prosthesis
WO2000007522A1 (en) 1998-07-31 2000-02-17 Novo Rps Ulc Small vessel expandable stent and method for production of same
US6143002A (en) * 1998-08-04 2000-11-07 Scimed Life Systems, Inc. System for delivering stents to bifurcation lesions
US6514281B1 (en) 1998-09-04 2003-02-04 Scimed Life Systems, Inc. System for delivering bifurcation stents
US7662409B2 (en) 1998-09-25 2010-02-16 Gel-Del Technologies, Inc. Protein matrix materials, devices and methods of making and using thereof
US8871267B2 (en) 1998-09-25 2014-10-28 Gel-Del Technologies, Inc. Protein matrix materials, devices and methods of making and using thereof
EP1031329A3 (en) * 1999-02-24 2002-08-21 Cordis Corporation Bifurcated axially flexible stent
AU765755B2 (en) * 1999-02-24 2003-09-25 Cordis Corporation Bifurcated axially flexible stent
US6579309B1 (en) 1999-08-06 2003-06-17 Biotronik Mess-Und Therapiegerate Gmbh & Co. Ingenieurburo Berlin Stent for vessel branchings
US8048142B2 (en) 2002-12-19 2011-11-01 Invatec S.R.L. Endolumenal prosthesis
US9107937B2 (en) 2003-08-26 2015-08-18 Gel-Del Technologies, Inc. Wound treatments with crosslinked protein amorphous biomaterials
US9999705B2 (en) 2003-08-26 2018-06-19 Gel-Del Technologies, Inc. Protein biomaterials and biocoacervates and methods of making and using thereof
US7465315B2 (en) 2003-11-19 2008-12-16 Advanced Cardiovascular Systems, Inc. Portal design for stent for treating bifurcated vessels
US8529939B2 (en) 2003-12-08 2013-09-10 Gel-Del Technologies, Inc. Mucoadhesive drug delivery devices and methods of making and using thereof
US10376354B2 (en) 2004-09-21 2019-08-13 Cook Medical Technologies Llc Side branch stent graft
EP1791497B1 (en) 2004-09-21 2018-11-21 Cook Medical Technologies LLC Side branch stent graft
US11771573B2 (en) 2004-09-21 2023-10-03 Cook Medical Technologies Llc Side branch stent graft
US9149355B2 (en) 2004-09-21 2015-10-06 Cook Medical Technologies Llc Side branch stent graft
US11191654B2 (en) 2004-09-21 2021-12-07 Cook Medical Technologies Llc Side branch stent graft
US9427340B2 (en) 2004-12-14 2016-08-30 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US8834554B2 (en) 2006-08-22 2014-09-16 Abbott Cardiovascular Systems Inc. Intravascular stent
US8882826B2 (en) 2006-08-22 2014-11-11 Abbott Cardiovascular Systems Inc. Intravascular stent
US9492297B2 (en) 2006-09-12 2016-11-15 Boston Scientific Scimed, Inc. Multilayer balloon for bifurcated stent delivery and methods of making and using the same
US8444700B2 (en) 2007-02-12 2013-05-21 Bioregeneration Gmbh Medical implant and process for the production thereof
US8936567B2 (en) 2007-11-14 2015-01-20 Boston Scientific Scimed, Inc. Balloon bifurcated lumen treatment
US11890371B2 (en) 2007-12-26 2024-02-06 Petvivo Holdings, Inc. Biocompatible protein-based particles and methods thereof
US8932340B2 (en) 2008-05-29 2015-01-13 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
US10016534B2 (en) 2008-11-17 2018-07-10 Gel-Del Technologies, Inc. Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof
EP2744457A1 (en) * 2011-08-19 2014-06-25 Al-saadon, Khalid Stent system, deployment apparatus and method for bifurcated lesion
US10463518B2 (en) 2011-08-19 2019-11-05 Khalid Al-Saadon Stent system, deployment apparatus and method for bifurcated lesion
US9486342B2 (en) 2011-08-19 2016-11-08 Khalid Al-Saadon Stent system, deployment apparatus and method for bifurcated lesion
US11376143B2 (en) 2011-08-19 2022-07-05 Khalid Al-Saadon Stent system deployment method for bifurcated lesion
EP2744457A4 (en) * 2011-08-19 2015-04-01 Khalid Al-Saadon Stent system, deployment apparatus and method for bifurcated lesion
CN103826577A (en) * 2011-08-19 2014-05-28 哈利德·艾尔-萨阿敦 Stent system, deployment apparatus and method for bifurcated lesion

Also Published As

Publication number Publication date
ID16864A (en) 1997-11-20
CA2253546A1 (en) 1997-11-13
US6811566B1 (en) 2004-11-02
US5906640A (en) 1999-05-25
DE69729886T2 (en) 2005-08-25
JP4659159B2 (en) 2011-03-30
EP0959811B1 (en) 2004-07-14
JP2001501496A (en) 2001-02-06
EP0959811A1 (en) 1999-12-01
ATE270860T1 (en) 2004-07-15
DE69729886D1 (en) 2004-08-19
CA2253546C (en) 2011-06-28
MY124237A (en) 2006-06-30
CA2175720A1 (en) 1997-11-04
AU2377397A (en) 1997-11-26
CA2175720C (en) 2011-11-29

Similar Documents

Publication Publication Date Title
US5906640A (en) Bifurcated stent and method for the manufacture and delivery of same
US6033435A (en) Bifurcated stent and method for the manufacture and delivery of same
US5755771A (en) Expandable stent and method of delivery of same
US6436133B1 (en) Expandable graft
JP3215807B2 (en) Expandable stent
EP1342455B1 (en) Expandable supportive branched endoluminal grafts
US6238409B1 (en) Articulated expandable intraluminal stent
EP1954218B1 (en) Twisting bifurcation delivery system
US8231669B2 (en) Tether guided stent side branch
US20050004656A1 (en) Expandable stent having plurality of interconnected expansion modules
US20080027533A1 (en) Dedicated bifurcation stent apparatus and method
JP2010246987A (en) Small vessel expandable stent and method for production of same
US7824438B2 (en) Method for placement of a stent assembly in a bifurcated vessel
US20090259299A1 (en) Side Branch Stent Having a Proximal Flexible Material Section
US8470017B2 (en) Balloon for use in placing stents in bifurcated vessels
US9186265B2 (en) Implantable medical device having a means for positioning it at the precise site of a branching of a blood vessel such as a coronary artery
AU769241B2 (en) Bifurcated stent and method for the manufacture of same
AU782512B2 (en) Expandable stent and method for delivery of same
MXPA97003222A (en) Expandable bifurced stent and method to paramolate mi

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN YU AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2253546

Country of ref document: CA

Kind code of ref document: A

Ref document number: 2253546

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 1997 539366

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1997919222

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1997919222

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09180146

Country of ref document: US

WWG Wipo information: grant in national office

Ref document number: 1997919222

Country of ref document: EP